putnam_CV_8_2_04 by y18a5zKA

VIEWS: 19 PAGES: 36

									                                                                                                    Rev. May 2010
                                              CURRICULUM VITAE

NAME:                                     Joe B. Putnam, Jr., M.D.


OFFICE ADDRESS:                           Department of Thoracic Surgery
                                          Vanderbilt University Medical Center
                                          609 Oxford House
                                          1313 21st Avenue South
                                          Nashville, TN 37232 –4682
                                          Phone: (615) 343 - 9202
                                          Fax:     (615) 322 - 3079
                                          E - mail: bill.putnam@vanderbilt.edu

                                          Thoracic Surgery
                                          c/o Surgical Services
                                          Nashville VA Medical Center
                                          VA Tennessee Valley Health Care System (TVHS)
                                          1310 24th Avenue South
                                          Nashville, Tennessee 37212 - 2637
                                          Phone: (615) 327 - 5356 x 5615
                                          Hospital: (615) 327 - 4751
                                          Fax:      (615) 321 - 6342

                                          Date/Place of Birth: September 26, 1953 / Franklin, NC

HOME ADDRESS:                             515 Westview Avenue
                                          Nashville, TN 37205 - 3283
                                           (615) 298 - 4272
                                          Spouse: Jacqueline

CITIZENSHIP:                              USA

Military or Other Governmental Service

        Director of Surgical Services, Naval Reserve Combat Zone Fleet Hospital 21,
                 Dallas, TX                                                                  1997 - 1998
        Head, Division of Cardiothoracic Surgery, Naval Hospital - San Diego, San
                 Diego, CA, OPERATION DESERT STORM                                           1990 - 1991
        Navy Commendation Medal                                                              1991
        United States Naval Reserve, Captain (O - 6), Medical Corps
                 Active reserve (SELRES)                                                     1985 - 1998
                 Inactive reserve (IRR)                                                      1998 - present


PRESENT TITLE AND AFFILIATION:

        Primary Appointment               Professor of Surgery and Chairman
                                          Ingram Professor of Cancer Research
                                          Department of Thoracic Surgery
                                          Vanderbilt University Medical Center
                                          Nashville, TN

        Secondary Appointment             Professor of Biomedical Informatics
                                          Department of Biomedical Informatics
                                          Vanderbilt University Medical Center
                                          Nashville, TN
Joe B. Putnam, Jr., M.D.                                                                   Rev: May 2010

EDUCATION:

        Degree-Granting Education

        The University of North Carolina at Chapel Hill, Doctor of Medicine,                               1975 - 1979
        The University of North Carolina at Chapel Hill, A.B. with Honors in Chemistry                     1971 - 1975

        Postgraduate Education and Training

        Resident in Thoracic Surgery, University of Michigan, Ann Arbor, MI                                1986 - 1988
        Chief Resident in Surgery, University of Rochester School of Medicine
                 and Dentistry, Rochester, NY                                                              1985 - 1986
        Senior Assistant Resident in Surgery, University of Rochester School of Medicine
                 and Dentistry, Rochester, NY                                                              1984 - 1985
        Medical Staff Fellow, Surgery Branch, National Cancer Institute, National Institutes of Health,
                 Bethesda, MD                                                                              1981 - 1984
        Junior Assistant Resident in Surgery, Johns Hopkins Hospital, Baltimore, MD                        1980 - 1981
        Surgical Internship, Johns Hopkins Hospital, Baltimore, MD                                         1979 - 1980

        Additional Education

        “Understanding the New World of Health Care”. John F. Kennedy School of Government, Harvard University,
        November 15 - 23, 1997.

        Rice Program for Managers, Rice University, School of Business, Houston, TX, January 16, 1999 - March 27,
        1999.

        National Comprehensive Cancer Network, NCCN Practice Guidelines for Esophageal Cancer, 2000

        Finance and Budgeting for Non - Financial Healthcare Professionals, University of Texas MD Anderson Cancer
        Center, Houston, TX - - October 24, 2002.

        American College Surgeons, Clinical Trials Methods Course – December, 2002.

        IRB Human Subjects Protections Training Program, Vanderbilt University Institutional Review Board, March,
        2004.

        Clinical Trials Program, American College of Surgeons, Chicago, IL - - June 16 - 19, 2004.

        Clinical Trials Research Methods, The Society of Thoracic Surgeons and the University of Colorado; Denver CO
        - - August, 2004 (5 days)

        Keck School of Public Health, Center for Continuing Professional Education, Program for Chiefs of Clinical
        Services, Harvard University, Boston, MA - - January 16 - 28, 2005.

        Vanderbilt University Medical Center, Academic Leadership Program, Nashville, TN - - March – December,
        2005


CREDENTIALS:

        Board Certification

        American Board of Surgery                             23087             1987
        American Board of Thoracic Surgery                     4870             1989 - 1999,
                                                                                Recertified 1998 - 2009
                                                                                Recertified 2008 - 2019



                                                           -2-
Joe B. Putnam, Jr., M.D.                                                                Rev: May 2010

        Licensures                                                               Expiration Dates

        North Carolina Medical Board                        24983                     9/26/10
        Texas State Board of Medical Examiners              H4040                     5/31/05
        DEA Registration                                    BP8620571                 3/31/13
        Tennessee Board of Medical Examiners                38176                     9/30/11

EXPERIENCE/SERVICE:

Academic Appointments

        Assistant Professor, Division of Thoracic and Cardiovascular Surgery,
                 University of Texas School of Medicine, Houston, TX                            1988 - 1994
        Assistant Surgeon, Assistant Professor of Surgery, Department of Thoracic Surgery,
                 University of Texas M. D. Anderson Cancer Center, Houston, TX                  1988 - 1994
        Associate Surgeon, Associate Professor of Thoracic & Cardiovascular Surgery,
                 Department of Thoracic & Cardiovascular Surgery,
                 University of Texas M. D. Anderson Cancer Center, Houston, TX                  1994 - 2000
        Deputy Chairman, Department of Thoracic and Cardiovascular Surgery,
                 University of Texas M. D. Anderson Cancer Center, Houston, TX                  1995 - 2004
        Professor of Surgery, Department of Thoracic and Cardiovascular Surgery,
                 University of Texas M. D. Anderson Cancer Center, Houston, TX                  2000 - 2004
        Chief, Section of Cardiothoracic Surgery, Nashville VA Medical Center,
                 VA Tennessee Valley Health Care System (TVHS), Nashville, TN                   2004 - 2005
        Professor of Surgery and Chairman, Department of Thoracic Surgery,
                 Vanderbilt University Medical Center, Nashville, TN                            2004 - present

Academic Administrative Appointments/Responsibilities

 University of Texas M. D. Anderson Cancer Center
       Deputy Director, Surgical Intensive Care Unit                                            1991 - 1992
       Search Committee for Chairman of the Dept. of Anesthesiology                             1992 - 1992
       Member - Division of Surgery and Anesthesiology Promotions Committee                     1995 - 1997
       Deputy Chair, Department of Thoracic and Cardiovascular Surgery                          1995 - 2004
       Director, Surgical Education and Training, Department of
                Thoracic and Cardiovascular Surgery                                             1992 - 2004
       Member, Division of Surgery Promotions Committee                                         1996 - 1998
       Member, Operating Room Committee                                                         1997 - 2004
       Program Director, Clinical and Resident Education,
                Department of Thoracic and Cardiovascular Surgery                               1997 - 2004
       Chairman, Division of Surgery Faculty Promotions Committee                               1998 - 2004
       Chairman, Operating Room Subcommittee on “Correct Site/Side” Surgery                     2002 - 2004
       Chairman, Revenue Cycle Advisory Committee                                               2002 - 2004
       Chairman, ad hoc Clinical Faculty Recognition Committee                                  2002 - 2003

 Vanderbilt University Medical Center

        Program Director, Residency Program in Thoracic and Cardiac Surgery                     2004 - present
        Member, Section of Surgical Sciences Promotion Committee                                2005 - present
        Member, Section of Surgical Sciences Quality Control Committee                          2006 - present

Institutional Committee Activities

 University of Texas M. D. Anderson Cancer Center
       Alternate, Research Committee                                                            1989 - 1994
       Member, Conduct of Care Subcommittee                                                     1989 - 1994




                                                         -3-
Joe B. Putnam, Jr., M.D.                                                              Rev: May 2010

Institutional Committee Activities (cont.)

        Thoracotomy Videotape Task Force                                                   1991 - 1992
        Member, Institutional Clinical Research Committee                                  1991 - 1992
        Member, Faculty Senate By - Laws Committee                                         1992 - 1994
        Member, Graduate Medical Education Committee                                       1992 - 1995
        Member, Medical Practice Subcommittee of the Medical Staff                         1992 - 1995
        Member, GI Tumor Group                                                             1993 - 1993
        Chairman, Faculty Senate Finance Committee                                         1993 - 1995
        Member, Task Force on Incentive - based Compensation for Faculty                   1994 - 1995
        Member, Disaster Subcommittee of the Medical Staff                                 1995 - 1995
        Member, Credentials Committee of the Medical Staff (CCMS)                          1995 - 1996
        Member, Executive Committee of the Faculty Senate                                  1995 - 1997
        Member, Executive Committee of the Medical Staff, (ECMS)                           1995 - 1997
        Member, Conflict of Interest Committee                                             1995 - 1998
        Participant, Telemedicine Conferences, M. D. Anderson Cancer Center Orlando        1995 - 2000
        Member, Clinical/Technical Team - Second Opinion at a Distance/Telemedicine        1997 - 1998
        Member, Roster of Services Committee                                               1997 - 1997
        Network Development/Contracting Team                                               1997 - 1999
        Managed Care Operations Committee                                                  1997 - 1999
        Member, Guidelines & Pathways Committee                                            1997 - 1998
        Member, Cancer Manager Project Leaders                                             1997 - 1999
        Member, Audit Committee                                                            1997 - 2001
        Member, 1997 Faculty Achievement Award Parent Committee                            1997 - 2001
        Member, PET Program Steering Committee                                             1998 - 2000
        Member, Cancer Consultant Operations Committee                                     1998 - 1999
        Co - Chairman, Committee on Faculty Peer and Grievance Review                      1998 - 2000
        Member, Graduate Medical Education Committee                                       1999 - 2004
        Co - Chairman, Diagnostic Imaging Users Group Committee                            1999 - 2000
        Member, Physicians Referral Service Executive Committee
                 Elected Representative – Division of Surgery                              1999 - 2004
        Member, Diagnostic Imaging Search Committee                                        2000 - 2001
        Conflict Management Advisory Committee                                             2000 - 2003
        Chairman, Conflict Management Advisory Committee                                   2001 - 2002
        Ombudsman Selection Committee                                                      2000 - 2001
        Member, Charles LeMaistre Outstanding Achievement Award Committee                  2000 - 2000
        Member, Promotion and Tenure Committee                                             2000 - 2004
        Chairman, GME Internal Review Sub - Committee for Pathology                        2002 - 2002
        Member, Credentials Committee of the Medical Staff                                 2002 - 2004
        Member, Conflict of Interest Committee                                             2002 - 2004
        Member, ad hoc Committee for Review of Non - Tenured Clinical Faculty              2003 - 2004

Vanderbilt University Medical Center

        Member, Vanderbilt Ingram Cancer Center                                            2004 - Present
        Member, Medical Center Medical Board                                               2004 - Present

PROFESSIONAL MEMBERSHIPS/ACTIVITIES

        Professional Society Activities, with Offices Held

        American Association for Cancer Research
        American Association for Thoracic Surgery:
               Member, Scientific Advisory and Government Relations Committee              2005 – 2007; 2009-2010
               Member, Thoracic Surgery Joint Workforce
               Member, Tech - Con Workforce                                                2005 – 2008
               Co - Chair, Tech - Con Workforce                                            2007 – 2008
               Member, Ad Hoc Program Review Committee                                     2009 – 2010
        American Board of Thoracic Surgery, guest examiner                                 2004 - present
                                                         -4-
Joe B. Putnam, Jr., M.D.                                                               Rev: May 2010

        Professional Society Activities, with Offices Held (cont.)

        American College of Chest Physicians
        American College of Surgeons:
                 Web Portal Committee, Oncology Group                                       2004 - present
                 Board of Governors (representing Southern Thoracic Surgical Association)   2007 - present
        American College of Surgeons Oncology Group
                 Chair, Thoracic Organ Site Committee,                                      2002 - present
                 Member, Executive Committee                                                2002 - present
        American Medical Association
        American Society for Clinical Oncology
                 Member, Scientific Program Committee                                       2008 - 2009
        Bayer Fellowships in Blood Conservation Selection Committee                         2005 - 2008
        European Association for Cardio - Thoracic Surgery
        General Thoracic Surgical Club
        Houston Surgical Society                                                            1996 - 2004
        International Association for the Study of Lung Cancer
                 Chair, Consensus Conf Committee on Adjuvant Therapy                        1993 - present
                 Chair, Bylaws Committee                                                    2006 - 2007
                 Member, Bylaws Committee,                                                  2005 - 2009
        Nashville Surgical Society                                                          2005 - present
        Sigma Xi (Life Member)                                                              1977 - present
        Society of Thoracic Surgeons:
                 Chair, Workforce on Clinical Trials                                        2002 - 2006
                 Member, National Database Task Force                                       2002 - 2003
                 Chair, Workforce on Research and Clinical Trials                           2003 - 2008
                 Member, Workforce on Annual Meeting
                 Co - Chair, Tech - Con Workforce                                           2007 - 2008
                 Member, Workforce on Media Relations and Communications                    2007 - 2013
                 Member, Workforce on Access and Publications                               2008 - 2011
                 Member, Workforce on Publication                                           2008 – 2011
        Society of Surgical Oncology
        Southern Surgical Association
        Southern Thoracic Surgical Association
        Texas Surgical Association
        The John Alexander Society
        UT MD Anderson Associates
        American Radium Society, Janeway Lecture Committee                                  2005
        Tennessee Oncology Practice Society                                                 2008 -
        National Quality Forum Perioperative Steering Committee                             2008
        Member, Thoracic Surgery Directors Association, Nominating Committee                2010
        Member, Technical Advisory Panel, National Quality Forum                            2010

        Local/State

        Tennessee Chapter, American College of Surgeons                                         2009-
        Charter Member, Institute for Responsible Dispute Resolution, Houston, TX               2001
        Planning Committee, Thoracic Surgery Lecture Series, Baylor College of Medicine, Department of
             Cardiovascular and Thoracic Surgery, Houston, TX                                   1996 - 2004.
        Member, Advisory/Operations Committee for the Center of Excellence in Minimally Invasive Surgery at
             Hermann Hospital, University of Texas Health Science Center at Houston             1993 - 1994
        Co - Chair, Esophageal Cancer Session. Multidisciplinary G.I. Cancer Retreat, University of Texas M. D.
             Anderson Cancer Center, Houston, TX                                                1992
        Coordinating Committee Interdisciplinary Oncology Conference, University of Texas Medical School, Houston,
              TX                                                                                1990 - 1991




                                                         -5-
Joe B. Putnam, Jr., M.D.                                                                 Rev: May 2010

    Professional Society Activities, with Offices Held (cont.)

    National and International:

        Chair, Surgery Committee, International Association for the Study of Lung Cancer,
        11th World Conference on Lung Cancer, Barcelona, Spain 3 - 6 July 2005                          2003 - 2005
        Chair, Bylaws Committee, International Association for the Study of Lung Cancer                 2005 - present
        NCI Thoracic / Lung Intergroup                                                                  2003 - present
        NCI GI Intergroup Esophagogastric Disease Site Working Group                                    2004 - present
        Program Committee, American Association of Thoracic Surgery                                     2004 - 2006
        American College of Surgeons Oncology Group (ACOSOG)                                            2002 - present
        Committee Member, American College of Surgeons, Commission on Cancer Disease Site Team          2002 - present
        Committee Member, Society of Thoracic Surgeons, National Databases Resource Group,              2002 - present
        Member, Society of Thoracic Surgeons, Nomenclature and Coding                                   2001 - 2005
        Member, Intergroup Lung Cancer Working Council, Randomized Trial Neoadjuvant
           Chemotherapy and Surgery versus Surgery Alone for Early Stage Lung Cancer “S9900”             1998
        Member, Radiation Therapy Oncology Group Thoracic Surgery Subcommittee                           1989 - 2001
        Member, Texas Medical Association Physician Oncology Program (POEP)                              1997
        Member, National Database Committee, National Thoracic Surgery Database,
            Society of Thoracic Surgeons, Chicago, IL                                                    1995 - 1997
        Chairman, Video Thoracoscopic Surgery Session, 4th European Congress of Video Surgery,
            Istanbul, Turkey                                                                             1994
        Member, Original Investigators Committee, 58th Annual Scientific Assembly,
            American College of Chest Physicians                                                         1991

TEACHING

        Courses Taught

        Instructor Advanced Cardiac Life Support Provider Course, The University of Texas M. D. Anderson Cancer
        Center, 1994 - 1998.

        Training Programs

        Video - Assisted Thoracoscopy Training Course, Department of Thoracic Surgery, 1992
        Coordinator, Third Year Students (Two week rotation) in Thoracic Surgery, 1988 - 2000

        Other Educational Programs

        Teaching Assistant - General Chemistry, Department of Chemistry,
              University of North Carolina at Chapel Hill                                                1974 - 1975.
        Student Project Director, Student Originated Studies, National Science Foundation, Department of Zoology,
            University of North Carolina at Chapel Hill                                                  1988 - 1994
        Surgical Lecture Series, Department of Surgery, University of Rochester Strong Memorial Hospital, Rochester,
              New York                                                                                   1985 - 1986
        Thoracic Surgery Lecture Series, Department of Thoracic Surgery, University of Texas M. D. Anderson Cancer
              Center                                                                                     1988 - 1994
        Instructor, Advanced Trauma Life Support Provider Courses, Southeast Trauma Educ Foundation 1994 - 1998
        Director, Clinical Education and Training, Department of Thoracic and Cardiovascular Surgery, University of
              Texas M. D. Anderson Cancer Center                                                         1996 - 2004
        Moderator, Institutional Grand Rounds Pearls - The Art and Science of Medicine, University of Texas M. D.
              Anderson Cancer Center,                                                                    Sep, 1999
        Moderator, Institutional Grand Rounds Pearls - The Art and Science of Medicine, University of Texas M. D.
              Anderson Cancer Center                                                                     Jun, 2001
        Moderator, Institutional Grand Rounds Pearls - The Art and Science of Medicine, University of Texas M. D.
              Anderson Cancer Center                                                                     Sep, 2002
        Program Director, Thoracic (aka Cardiothoracic) Surgery, Vanderbilt University Medical Center, Nashville,
              Tennessee,                                                                                 2004 - present

                                                          -6-
Joe B. Putnam, Jr., M.D.                                                               Rev: May 2010


        Supervisory Teaching

        Direct Supervision
                Undergraduate, Medical, and Allied Health Students

               Graduate and Postgraduate Students
                   Suk - Joo Rha, M.D., Postdoctoral Fellow         1/98 - 12/99
                   Imran Mohiuddin, M.D., Researcher                1/99 - 12/01
                   Freddy Angulo, M.D., Observer                    2/99 - 9/00
                   Jin - Sun Kim, M.D., Postdoctoral Fellow         7/05 - 3/08
                   Lori Ferranti, PhD Candidate                     2006 – 2009
        Mentoring:

                Faculty:                  Eric S. Lambright, M.D.: 2004-present
                                          Eric L. Grogan, M.D.: 2008-present
                 Residents:               Gary Hochheiser, M.D.: 2001-2003
                                          Tarek Absi, M.D.: 2003-2005
                                          Robert DuBose, M.D.: 2005-2007
                                          Tammy Baxter, M.D.: 2006-2008
                                           Jared Antevil, M.D.: 2007-2009
                                          Alex Karavas, M.D.: 2008- 2010
                                          Daniel Cuadrado, M.D.: 2008 – 2011
                                          James Mykytenko, M.D.: 2009 – 2012
                Pre-Doctoral Trainee:     Stephen Deppen, M.S.: 2008 - present


    Outside of Current Institution:

        Organization of National or International Conferences/Symposia

        The Society of Surgical Oncology‟s 49th Cancer, Thoracic Oncology Session;
                 Symposium, Atlanta, GA, Moderator,                                                    1997
        American Radium Society 80th Annual Meeting, Lung Cancer,
                 Monte Carlo, Monaco, Discussion Panel                                                 1998
        American Radium Society 80th Annual Meeting, Esophageal Cancer
                 Monte Carlo, Monaco, Moderator                                                       1998
        American Radium Society Program Committee,                                            2003 – present
        American Association for Thoracic Surgery, Program Review Committee                   2003 – present
        American Association for Thoracic Surgery, Scientific and Government Relations,
                      AHRQ/CMS Subcommittee,                                                  2004 – 2007
        Society of Thoracic Surgeons, Chairman, Workforce on Research and Clinical Trials,    2004 – present
        Society of Thoracic Surgeons, Member, Workforce on Publications                       2008 - 2009
        Society of Thoracic Surgeons, Member, Workforce on Media Relations &
                 Communications                                                               2008 - 2009
        Education Committee, International Association for the Study of Lung Cancer,          2003 – present
        Chair, Surgery Abstract Committee, International Association for the Study of Lung
                 Cancer; World Congress, Barcelona, Spain                                     2005
        National Cancer Institute, Thoracic Malignancies Steering Committee                   2008 - present

RESEARCH

Grants and Contracts

       Principal Investigator, A Prospective Randomized Study of Pleural Drainage vs. Tube Thoracostomy and
        Pleurodesis for Treatment of Pleural Effusions, Denver Biomaterials, Inc., Golden CO,
        4/4/94 - 4/4/96, $33,750 ($16,875/year)
       Principal Investigator, Ethicon Endosurgery, Residents and Fellows Training and Development, Cincinnati, OH,
        5/1/94 - 4/30/96, $12,811 ($6,400/year)
                                                        -7-
Joe B. Putnam, Jr., M.D.                                                                      Rev: May 2010


    Grants and Contracts (cont.)

         Institutional Principal Investigator, Co - Investigator for National Study, A Multicenter Phase III Trial to Evaluate
          the Efficacy of Recombinant Human GM - CSF (rhu GM - CSF) for Prophylaxis of Postoperative Infection,
          Immunex Corporation, Seattle, WA,
          4/95 - 4/96, $250,000 ($250,000/year)
         Principal Investigator, In Vitro and in Vivo Studies to Enhance Isolated Single Lung Perfusion For the Treatment
          of Sarcomatous Pulmonary Metastases In a Rodent Model, University of Texas M. D. Anderson Cancer Center,
          Houston, TX, Physician Referral Service Research
          2/1/98 - 1/31/99, Award $22,178 ($22,178/year)
         Co - Investigator, University of Texas SPORE in Lung Cancer, NCI
          9/1/98 - 8/31/99, $3,828,945 ($3,828,945/year)
         Co - Investigator, University of Texas SPORE in Lung Cancer, NIH
          9/01/99 - 8/31/01, $24,960 ($12,480/year)
         Co - Investigator, Restoration of Apoptosis in Cancer, NIH/NCI
          5/01/00 - 4/30/01, $690,030 ($690,030/year)
         Principal Investigator, Evaluation of Radiofrequency Ablation (RFA) for Malignant Lung Tumors, Rita Medical
          Services, Mountain View, CA
          8/10/00 - 8/31/01, $17,090 ($17,090/year)
         Co - Investigator, Using a novel system to assess and manage post - operative pain and other symptoms in patients
          with lung cancer, University of Texas M. D. Anderson Cancer Center, Houston, TX
          12/01/01 - 11/30/03, $299,884 ($149,942/year)
         Institutional Principle - Investigator, A Randomized Phase III Trial Surgery Alone or Surgery Plus Preoperative
          Paclitaxel/Carboplatin in Clinical Stage IB (T2NO), II (T2 - 2N1, T3NO) and Selected IIIA (T3N1) Non - Small
          Cell Lung Cancer (NSCLC), Southwest Oncology Group (SWOG), San Antonio, TX
          1/10/01 - 12/31/04, $256,950 ($85,650/year)
         Co - Investigator, 5 U10 CA076001 05, American College of Surgeons Oncology Group, Duke University,
          Durham, NC 5/01/02 - 4/30/10, ($128,000).
         Database Administrator, University of Texas SPORE in Lung Cancer, NIH
          9/01/02 - 4/30/03, ($100,000) Principal Investigator
         Principal Investigator, “A Multi - Center, Randomized, Double - Blind, Placebo - Controlled, Parallel Design, 2 -
          Arm Study to Investigate the Effect of Aprotinin on Transfusion Requirements in Patients Undergoing Surgical
          Procedures for Lung Cancer or Esophageal Cancer” Bayer – BAY Number BAY a 0128; Study Number 11800
          January 1, 2006 – December 31, 2008

Patents

#6,699,231 March 2, 2004; Sterman WD, Stevens JH, Gifford III HS, Siegel LC, Putnam, JB Jr.. Assignee:
    Heartport, Inc. (Redwood City, CA (appl. No, 223229; Filed December 30, 1998). “Methods and apparatus for
    perfusion of isolated tissue structure”.

Protocols

Collaborator, A Prospective Randomized Three - Arm Phase III Trial Comparing Trimodality Therapy Cisplatin, 5 - FU,
    Radiotherapy and Surgery, Adjuvant Chemotherapy (Cisplatin and 5 - FU) and Surgery Alone For Esophageal Cancer,
    CALGB 9X9L, University of Maryland School of Medicine, Baltimore, MD, 1995

Co - Investigator, A Phase I Study of E1A Gene Therapy for Patients with Metastatic Breast or Epithelial Ovarian Cancer
    that Overexpress HER - 2/neu, DM 94 - 129, University of Texas M.D. Anderson Cancer Center, 1996 - 1998 (Closed
    4/13/98)

Collaborator, A Phase II Study of  - Difluoromethyl ornithine (DFMO) in Patients with Barrett‟s Esophagus with
    Dysplasia, DM 98 - 204, University of Texas M.D. Anderson Cancer Center, Division of Medicine, 1999 - 5/02

Collaborator, Phase II Study of Preoperative CPT - 11/Cisplatin followed by Concurrent 5 - FU/Taxol and Radiotherapy
    in Patients with Potentially Resectable Carcinoma of the Esophagus or GE Junction DM98 - 349, University of Texas
    M.D. Anderson Cancer Center, 1999 - 11/00

                                                              -8-
Joe B. Putnam, Jr., M.D.                                                                   Rev: May 2010


Protocols (cont.)

Collaborator, An Efficacy Study of Adenoviral Vector Expressing Wild type p53 (AD - p53) Administered Intralesionally
    as an Adjunct to Radiation Therapy in Patients with Non - Small Cell Cancer, GS 97 - 183, University of Texas M.D.
    Anderson Cancer Center, 1998 - 6/00

Principal Investigator, Lung Transplantation for End Stage Pulmonary Diseases, HSC - MD - 90 - 061, University of
    Texas Health Science Center at Houston, 1990 - 1993 (Closed)

Principal Investigator, Acute and Chronic Studies on Radioablation of Porcine Lung Parenchyma, IACUC 02 - 99 - 0112,
    University of Texas M. D. Anderson Cancer Center, 1999 - 2002

Study Co - Chairman, Measurement and Prediction of Postoperative Pain and Analgesic Requirement, ID00 - 370,
    University of Texas M. D. Anderson Cancer Center, 2001

Collaborator, Preoperative Cardiopulmonary Limit Reached (Closed) Function Testing to Predict Postoperative
    Morbidity and Mortality in the High Risk Patient with Resectable Lung Cancer, ID 89 - 009, University of Texas M.D.
    Anderson Cancer Center, 1989 - 1993

Principal Investigator, A Study of Lung Transplantation for the Cancer Patients: Treatment of Patients with Pulmonary
    Metastases from Osteogenic and Soft Tissue Sarcomas, ID89 - 030, University of Texas M.D. Anderson Cancer
    Center, 1987 - 1988(Closed)

Collaborator, Phase III Double - Blind Randomized Trial of 13 - cis Retinoic Acid (13 - cRA) to Prevent Second Primary
    Tumors (SPTs) in Stage I Non - small Cell Lung Cancer, ID 91 - 025, University of Texas M.D. Anderson Cancer
    Center, 1992 - 9/98

Collaborator, Early Detection of Second Primary Lung Cancers By Sputum Cytology Immunostaining, ID 91 - 029,
    University of Texas M.D. Anderson Cancer Center, 1992 - 6/00

Co - Chairman, Phase II study of combined modality treatment for resectable non - small cell superior sulcus tumor
    (SST), ID 92 - 038, University of Texas M.D. Anderson Cancer Center, 1993 – 2004

Co - Investigator, An open study to assess concentration of CP - 99219 in whole lung tissue and serum after
    administration of multiple doses to patients undergoing thoracotomy, ID 94 - 046, University of Texas M.D. Anderson
    Cancer Center, 1994 - 1997

Collaborator, A phase I study of continuous infusion low dose paclitaxel and concurrent radiotherapy for unresectable
    esophageal cancer,. ID 95 - 071, University of Texas M.D. Anderson Cancer Center, 1995 - 8/01

Principal Investigator, Phase I evaluation of single pass pulmonary perfusion with Adriamycin for sarcomatous
    (pulmonary) metastases, ID 95 - 219, University of Texas M.D. Anderson Cancer Center 1995 - 2004

Collaborator, A multi - center study of the correlation between the findings of atypical/malignant cells in sputum and
    fluorescence bronchoscopy using the LIFE Imaging System, and white light bronchoscopy, ID 95 - 230, University of
    Texas M.D. Anderson Cancer Center, 1996 - 10/98

Collaborator, Phase II Trial of Induction Paclitaxel/Carboplatin in Clinical Stage Ib (T2NO), Stage II (T1 - 2N1), and
    Selected Stage IIIa (T3NO - 1) Non - small Cell Lung Cancer (NSCLC), ID 96 - 038, University of Texas M.D.
    Anderson Cancer Center, 1996 - 1999 (Closed)

Collaborator, Phase I Study of Intratumoral E1A Gene Therapy for Patients with Unresectable or Metastatic Solid Tumors
    that Overexpress HER - 2/new, ID 96 - 117, University of Texas M.D. Anderson Cancer Center, 1996 - 1999 (Closed)

Study Chairperson, A Randomized Phase III Trial Surgery Alone or Surgery Plus Preoperative Paclitaxel/Carboplatin in
    Clinical Stage IB (T2N0), II (T1 - 2N1, T3N0) and Selected IIIA (T#N1) Non - Small Cell Lung Cancer (NSCLC), ID
    99 - 400, University of Texas M.D. Anderson Cancer Center, 1999 - 2004

                                                           -9-
Joe B. Putnam, Jr., M.D.                                                                   Rev: May 2010

Protocols (cont.)

Collaborator, A Phase II Study of Preoperative 5 - FU, Taxol and Cisplatin Followed by Concurrent 5 - FU/Cisplatin and
    Radiotherapy in Patients with Potentially Resectable Carcinoma of the Esophagus or GE Junction, ID 96 - 189,
    University of Texas M.D. Anderson Cancer Center, 1996 - 1998 (Closed)

Collaborator, Phase II Study of Postoperative Adjuvant Therapy in Patients With Completely Resected Stage II and stage
    IIIa Non - small Cell Lung Cancer (NSCLC), RTOG 97 - 05, University of Texas M.D. Anderson Cancer Center, 1997
    - 7/98

Collaborator, A Phase III Intergroup Trial: A Prospective Randomized Comparison of Combined Modality Therapy for
    Carcinoma of the Esophagus: Chemotherapy Plus Surgery Versus Surgery Alone for Patients with Local Regional
    Disease, RTOG 89 - 11, University of Texas M.D. Anderson Cancer Center, 1990 - 1995, (Closed)

Co - Principal Investigator, Pilot Study of Combined Approach with Chemotherapy, Radiation Therapy, and Surgery for
    Advanced Thymoma,. RTOG 90 - 17, University of Texas M.D. Anderson Cancer Center, 1990 - 1992 (Study Closed)

Collaborator, Prospective Randomized Trial of Postoperative Adjuvant Therapy in Patients with Completely Resected
    Stage II and Stage IIIa Non - small Cell Lung Cancer, RTOG 91 - 05, University of Texas M.D. Anderson Cancer
    Center, 1993 - 1996 (Study Closed)

Collaborator, Randomized Phase II Study of Chemotherapy/Radiation Therapy Combination for Favorable Patients with
    Locally Advanced Inoperable Non - small Cell Lung Cancer, RTOG 92 - 04, University of Texas M.D. Anderson
    Cancer Center, 1992 - 1994 (Study Closed)

Collaborator, A Phase III Comparison Between Concurrent Chemotherapy Plus Radiotherapy, and Concurrent
    Chemotherapy Plus Radiotherapy Followed by Surgical Resection for Stage IIIa (N2) Non - small Cell Lung Cancer,
    RTOG 93 - 09, University of Texas M.D. Anderson Cancer Center, 1994 - 6/02.

Collaborator, A Phase III Intergroup Randomized Comparison of Combined Modality Therapy for Carcinoma of the
    Esophagus: High Dose vs. Conventional Dose Radiation Therapy, RTOG 94 - 05, University of Texas M.D. Anderson
    Cancer Center, 1996 - 4/00

Collaborator, A Three Arm Phase III Study of Concomitant vs. Sequential Chemotherapy and Thoracic Radiotherapy for
    Patients with Locally Advanced Inoperable Non - small Cell Lung Cancer, RTOG 94 - 10, University of Texas M.D.
    Anderson Cancer Center, 1994 - 8/98

Study Co - Chairman, A Phase III Study of Adjuvant Chemotherapy after Resection for Patients with T 2N0 Stage I Non -
    Small Cell Carcinoma of the Lung, RTOG 96 - 16, University of Texas M.D. Anderson Cancer Center, 1997 - 2004

Collaborator, Phase II Study of Postoperative Adjuvant Therapy in Patients With Completely Resected Stage II and stage
    IIIa Non - small Cell Lung Cancer (NSCLC), RTOG 97 - 05, University of Texas M.D. Anderson Cancer Center, 1997
    - 7/98

Collaborator, Clinical Protocol for Modification on Oncogene and Tumor Suppressor Gene Expression in Non - small
    Cell Lung Cancer (NSCLC), THS 92 - 001, University of Texas M.D. Anderson Cancer Center, 1992 - 1992 (Closed)

Principal Investigator, A Prospective Evaluation of Video - assisted (Teaching Study) Thoracoscopy (VAT) Techniques
    in Thoracic Surgery”, THS 92 - 002, University of Texas M.D. Anderson Cancer Center, 1992 - 1992 (Closed)

Collaborator, Clinical protocol for modification of mutant K - ras gene expression in non - small cell lung cancer
    (NSCLC), THS 94 - 001, University of Texas M.D. Anderson Cancer Center, 1995 - 1997 (Closed)

Collaborator, Clinical Protocol for Modification of Tumor Suppressor Gene Expression and Induction of Apoptosis in
    Non - small Cell Lung Cancer (NSCLC) with an Adenovirus Vector Expressing Wild - type p53 and Cisplatin, THS
    94 - 002, University of Texas M.D. Anderson Cancer Center, 1995 - 1998 (Closed)




                                                           - 10 -
Joe B. Putnam, Jr., M.D.                                                                  Rev: May 2010

Protocols (cont.)

Principal Investigator, A Prospective Randomized Study of Pleural Drainage vs. Tube Thoracoscopy and Pleurodesis for
    Treatment of Pleural Effusions, THS 94 - 003, University of Texas M.D. Anderson Cancer Center, 1994 - 1997
    (Closed)

Principal Investigator, A Multicenter Phase III Trial to Evaluate the Efficacy of Recombinant Human GM - CSF (rhu
GM-CSF) for Prophylaxis of Postoperative Infection, THS 94 - 004, University of Texas M.D. Anderson Cancer Center,
1994 - 1996 (Closed)

HONORS AND AWARDS:

         Eagle Scout, Boy Scouts of America                                                       1970
         A. B. with Honors in Chemistry, University of North Carolina at Chapel Hill              1975
         Sigma Xi Prize for Undergraduate Research, University of North Carolina at Chapel Hill   1975
         Finalist - The Paul C. Samson Award for Outstanding Resident Manuscript
                   The Samson Thoracic Surgical Society                                           1983
         Outstanding Resident - Surgery, University of Rochester School of Medicine,
                   Class of 1986                                                                  1986
         Physician‟s Recognition Award - American Medical Association                             1997 - 2000
         The Best Doctors in America - Woodward/White, Inc, “Elected by his peers
                   for inclusion in Best Doctors in America from 1996 to 2009”                   1996 - 2009
         Nations‟ Top Cancer Specialist for Women                                                 1999
         Who‟s Who in America - Science and Engineering 5th Edition                               2000
         Alley - Sheridan Fellow, “Understanding the New World of Health Care”
                    Harvard University, Boston, MA.; Awarded by The Thoracic Surgery
                    Foundation for Research and Education                                         2002
         Houston‟s Best Doctors, Inside Houston                                                   2002
         Teaching Award – The University of Texas – Houston Medical School
                   “The Surgery Chief Resident Award”                                             2002
         Who‟s Who in America                                                                     2003
         Margaret W. Elkins Endowment for Research in Thoracic Surgical Oncology                  2002 - 2004
         The Charles and Beverly Adams Fund for Thoracic Surgical Oncology                        1998 - 2004
         America‟s Top Doctors – Castle Connolly                                                  2006 - present

         2007 Top Scoring Physician – Vanderbilt Medical Group – Surgical Specialty Services,
                Overall Quality of Doctor Care (100%)                                         2007
                [Based on the Professional Research Consultants, Inc, 2006 National Database]

         2008 Top Scoring Clinic [Thoracic Surgery] – Vanderbilt Medical Group – Surgical Specialty Services,
                Overall Quality of Care (100th percentile)                                     2008
                Likelihood to Recommend (100th percentile)                                     2008
                [Based on the Professional Research Consultants, Inc., 2007 National Database]

         2009 Top Scoring Physician – Vanderbilt Medical Group – Surgical Specialty Services,
                Overall Quality of Doctor Care (100%)                                         2009
                [Based on the Professional Research Consultants, Inc, 2008 National Database]

PUBLICATIONS:

    Articles in Peer-Reviewed Journals

    1.   Putnam, JB Jr., and Pedersen, L.G. Discovery of a 3‟, 5‟ - guanosine monophosphate simulating factor in
         amoebae of Dictyostelium discoideum. Biochim. Biophys. Acta, 411:168 - 170, 1975.
    2.   Peacock, L.A., Putnam, JB Jr., and Pedersen, LG. Massive body collisions with the solar system.
         Astronomy Quarterly, 1:16 - 18, 1977.
    3.   Eslava, L.A., Putnam, JB Jr., and Pedersen, L.G. An ab initio investigation of molecules with a disulfide
         bond: (HS)2 , (CH3S)2 and cystine. Intl J Peptide Protein Res., 11:149 - 153, 1978.

                                                          - 11 -
Joe B. Putnam, Jr., M.D.                                                                      Rev: May 2010

Articles in Peer-Reviewed Journals (cont.)

       4.   Roth, J.A., Grimm, E.A., Osborne, B.A., Putnam, JB Jr., Davidson, D.D., and Ames, R.S. Suppressive
            immunoregulatory factors produced by tumors. Lyphokine Res., 2:67 - 73, 1983.
       5.   Putnam, JB Jr., Roth, J.A., Wesley, M.N., Johnston, M.R., and Rosenberg, S.A. Survival following
            aggressive resection of pulmonary metastases form osteogenic sarcoma: analysis of prognostic factors. Ann
            Thor Surg, 38:516 - 523, 1983.
       6.   Putnam, JB Jr., Roth, J.A., Wesley, M.N., Johnston, M.R., and Rosenberg, S.A. Analysis of prognostic
            factors in patients undergoing resection of pulmonary metastases from soft tissue sarcomas. J Thor
            Cardiovasc Surg, 87:260 - 267, 1984.
       7.   Roth, J.A., Putnam, JB Jr., Wesley, M.N., and Rosenberg, S.A. Differing determinants of prognosis
            following resection of pulmonary metastases from osteogenic and soft tissue sarcoma patients. Cancer,
            55:1361 - 1366, 1985.
       8.   Davidson, D.D., Carney, D.N., Putnam, JB Jr., Sugarbaker, P.H., and Roth, J.A. Suppression of murine
            immunologic functions by fresh and cultured human tumor extracts. J. Surg. Res., 38:289 - 297, 1985.
       9.   Putnam, JB Jr., and Roth, J.A. Identification and characterization of a tumor - derived immunosuppressive
            factor from murine melanoma K - 1735. Cancer Immunol. Immunother., 19:90 - 100, 1985.
      10.   Roth, J.A., Pass, H.I., Wesley, M.N., White, D., Putnam, JB Jr., and Seipp, C. Comparison of median
            sternotomy and thoracotomy for resection of pulmonary metastases in patients with adult soft tissue
            sarcomas. Ann Thor Surg, 42:134 - 138, 1986.
      11.   Putnam, JB Jr., Lemmer, J.H., Rocchini, A., and Bove, E.L. Embolectomy for acute pulmonary artery
            occlusion following Fontan procedure. Ann Thor Surg, 45:335 - 336, 1988.
      12.   Putnam, JB Jr., Schantz, S.P., Pugh, W.C., Hickey, R.C., Samaan, N.A., Garza, R., and Suda, R.W.
            Extended en bloc resection of a primary mediastinal parathyroid carcinoma. Ann Thor Surg, 50:138 - 140,
            1990.
      13.   Murphy, M.C., Sweeney, M.S., Putnam, JB Jr., Walker, W.E., Frazier, O.H., Ott, D.A., and Cooley, D.A.
            Surgical treatment of cardiac tumors: A 25 - year experience. Ann Thor Surg, 49:612 - 617, 1990.
      14.   Putnam, JB Jr., Lammermeier, D.E., Colon, R., McMurtrey, M.J., Ali, M.K., and Roth, J.A. Predicted
            pulmonary function and survival after pneumonectomy for primary lung carcinoma. Ann Thor Surg, 49:909 -
            914, 1990.
      15.   Bolling, S.F., Putnam, JB Jr., Abrams, G.D., McKay, A.M., and Deeb, G.M. Hemodynamics versus biopsy
            during cardiac transplant rejection. Ann Thor Surg, 51:52 - 55, 1991.
      16.   Lanza, L.A. *, Putnam, JB Jr., Benjamin, R.S., and Roth, J.A. Response to chemotherapy does not predict
            survival after resection of sarcomatous pulmonary metastases. Ann Thor Surg, 51:219 - 224, 1991.
      17.   Putnam, JB Jr., Bolling, S.F., and Kirsh, M.M. Procainamide - induced respiratory insufficiency following
            cardiopulmonary bypass. Ann Thor Surg, 51:482 - 483, 1991.
      18.   Casson, A.G. *, Putnam, JB Jr., Natarajan, G., Johnston, D.A., Mountain, C., McMurtrey, M., and Roth J.A.
            Efficacy of pulmonary metastasectomy for recurrent soft - tissue sarcoma. J Surg Oncol 47:1 - 4, May, 1991.
      19.   Putnam, JB Jr., Sweeney, M.S., Colon, R., Lanza, LA, Frazier, O.H., and Cooley, D.A. Primary cardiac
            sarcomas. Ann Thor Surg, 51:906 - 910, 1991.
      20.   Myers, S.I., Harward, T.R., Putnam, JB Jr., and Frazier, O.H. Vascular trauma as a result of therapeutic
            procedures for the treatment of malignancy. J. Vasc. Surg., 14:314 - 319, 1991.
      21.   Gorenstein, L.A., Putnam, JB Jr., Natarajan, G., Balch, C.A., and Roth, J.A. Improved survival after
            resection of pulmonary metastases from malignant melanoma. Ann Thor Surg, 52:204 - 210, 1991.
      23.   Casson, A.G.*, Putnam, JB Jr., Natarajan, G., Johnston, D.A., Mountain, C., McMurtrey, M., et al. Five -
            year survival after pulmonary metastasectomy for adult soft tissue sarcoma. Cancer, 69: 661 - 668, 1992.
      24.   Morice, R.C., Peters, E.J., Ryan, M.B., Putnam, JB Jr., Ali, M.K., and Roth, J.A. Exercise testing in the
            evaluation of patients at high risk for complications from lung resection. Chest, 101:356 - 361, 1992.
      25.   Gorenstein, L.A.*, and Putnam, JB Jr., Resection of pulmonary metastasis to the azygous lobe from a
            malignant fibrous histiocytoma. Chest, 101:863 - 865, 1992.
      26.   Gauwitz, M., Ellerbroek, N., Komaki, R., Putnam, JB Jr., Ryan, M., and Cundiff, B.S., High dose
            endobronchial irradiation in recurrent bronchogenic carcinoma. Int. J. Rad. Oncol. Biol. Phys., 23:397 - 400,
            1992.
      27.   Lanza, L.A.*, Natarajan, G., Roth, J.A., and Putnam, JB Jr., Long - term survival after resection of
            pulmonary metastases from carcinoma of the breast. Ann Thor Surg, 54:244 - 248, 1992.
*
    Resident / Fellow: Dr. Putnam served as mentor/faculty advisor



                                                                     - 12 -
Joe B. Putnam, Jr., M.D.                                                                      Rev: May 2010

Articles in Peer-Reviewed Journals (cont.)

      28. Cybulsky, I.J., Lanza, L.A., Ryan, M.B., Putnam, JB Jr., McMurtrey, M.J., and Roth, J.A. Prognostic
          significance of computed tomography in resected N2 lung cancer. Ann Thor Surg, 54:533 - 537, 1992.
      29. Shin, D.M., El - Naggar, A.K., Putnam, JB Jr., Komaki, R., and Hong, W.K. Pathologic remission of
          invasive thymoma after induction chemotherapy. Case Report, Cancer Bull., 44:346 - 348, 1992.
      30. Pollack, A., Komaki, R., Cox, J.D., Ro, J.Y., Oswald, M.J., Shin, D.M., and Putnam, JB Jr., Thymoma:
          Treatment and prognosis. Int. J. Radiat. Oncol. Biol. Phys., 23:1037 - 1043, 1992.
      31. Ajani, J.A., Roth, J.A., Ryan, M.B., Putnam, JB Jr., Pazdur, R., Levin, B., Gutterman, J.U., and McMurtrey,
          M. Intensive preoperative chemotherapy with colony stimulating factor for resectable adenocarcinoma of the
          esophagus or gastroesophageal junction. J. Clin. Oncol. 11:22 - 28, 1993.
      32. Putnam, JB Jr., Suell, D.M., Roth, J.A., and Natarajan, G. Extended resection of pulmonary metastases: Is
          the risk justified? Ann Thor Surg, 55:1440 - 1446, 1993.
      33. Sella, A., Swanson, D.A., Ro, J.Y., Putnam, JB Jr., Amato, R.J., Markowitz, A.V., and Logothetis, C.J.
          Surgery following response to interferon - based therapy for residual renal cell carcinoma. J. Urol., 149:19 -
          21, 1993.
      34. Putnam, JB Jr., Suell, D.A., McMurtrey, M.J., Ryan, M.B., Walsh, G.L., Natarajan, G., and Roth, J.A.
          Comparison of three techniques of esophagectomy within a residency training program. Ann Thor Surg,
          57:319 - 325, 1994.
      34. Park, H.S., Shin, D.M., Komaki, R., Lee, J.S., Pollack, A., and Putnam, JB Jr., Thymoma: A retrospective
          study of 87 cases. Cancer, 73:2491 - 2498, 1994.
      35. Putnam, JB Jr., Dignani, C., Mehra, R.C., Anaissie, E.J., and Morice, R.C. Acute airway obstruction and
          necrotizing tracheobronchitis form invasive mycosis. Chest, 106:1265 - 1267, 1994.
      36. Walsh, G.L., Morice, R.C., Putnam, JB Jr., Nesbitt, J.C., McMurtrey, M.J., Ryan, M.B., Reising, J., Willis,
          K.M., Morton, J.D., and Roth, J.A. Resection of lung cancer is justified in high risk patients selected by
          exercise oxygen consumption. Lung Cancer: 12: 301, 1995.
      37. Roth, J.A., Fossella, F., Komaki, R., Ryan, M.B., Putnam, JB Jr., Lee, J.S., Dhingra, H., DeCaro, L.,
          Chason, M., McGavran, M., Atkinson, E.N., and Hong, W.K. A randomized trial comparing perioperative
          chemotherapy and surgery with surgery alone in resectable stage IIIA non - small cell lung cancer. J. Natl.
          Cancer Inst., 86:673 - 680, 1994.
      38. Ajani, J.A., Roth, J.A., Putnam, JB Jr., Walsh, G.L., Lynch, P.M., Roubein, L.D., Ryan, M.B., Natarajan,
          G., and Gould, P. Feasibility of five courses of preoperative chemotherapy in patients with resectable
          adenocarcinoma of the esophagus or gastroesophageal junction. Euro. J. Cancer, 31A:665 - 670, 1995.
      39. Nesbitt, J.C., Putnam, JB Jr., Walsh, G.L., Roth, J.A., and Mountain, C.F. Survival in early stage non -
          small cell lung cancer. Ann Thor Surg, 60:466 - 472, 1995.
      40. Soysal, O. *, Walsh, G.L., Nesbitt, J.C., McMurtrey, M.J., Roth, J.A., and Putnam, JB Jr., Resection of
          sternal tumors: extent, reconstruction, and survival. Ann Thor Surg, 60:1353 - 1359, 1995.
      41. Walsh, G.L., O‟Conner, M., Willis, K.M., Milas, M., Wong, R.S., Nesbitt, J.C., Putnam, JB Jr., Lee, J., and
          Roth, J.A. Is follow - up of lung cancer patients after resection medically indicated and cost - effective? Ann
          Thor Surg, 60:1563 - 1570, 1995.
      42. Roth, J.A., Nguyen, D., Lawrence, D.D., Kemp, B.L., Carrasco, C.H., Ferson, D.Z., Hong, W.K., Komaki, R.,
          Lee, J.J., Nesbitt, J.C., Pisters, K.M.W., Putnam, JB Jr., Shea, R., Shin, D.M., Walsh, G.L., Dolormente,
          N.N., Han, C - I., Martin, F.D., Yen, N., Stephens, L.C., McDonnell, T.J., Mukhopadhyay, T., and Cai, D.
          Retrovirus - medicated wild - type p53 gene transfer to tumors of patients with lung cancer. Nat. Med., 2:985
          - 991, 1996.
      43. Tanguay S.* Swanson, D.A., and Putnam, JB Jr.. Renal cell carcinoma metastatic to the lung: potential
          benefit of the combination of biological therapy and surgery. J. Urol. 156:1586 - 1589, 1996.
      44. Roth, J.A., Beech, D.J., Putnam, JB Jr., Pollock, R.E., Pate, S.R., Fidler, I.J., and Benjamin, R.S. Treatment
          of the patient with lung metastases, Durr. Probl. Surg., 33:881 - 952, 1996.
      45. Perkins, P., Kemp, B.L., Putnam, JB Jr., and Cox, J.D.. Pretreatment characterization of carcinoid tumors of
          the lung which predict aggressive behavior. Am. J. Clin. Oncol., 20:285 - 88, 1997.
      46. Pastorino, U., Buyse, M., Friedel, G., Ginsberg, R.J., Goldstraw, P., Johnston, M., McCormack, P., Pass, H.,
          and Putnam, JB Jr. Long - term results of lung metastasectomy: prognostic analyses based on 5,206 cases.
          J Thor Cardiovasc Surg, 113:37 - 49, 1997.
      47. Ferson, D.Z., Nesbitt, J.C., Nesbitt, K.K., Walsh, G.L., Putnam, JB Jr., Schrump, D.S., Johansen, M.J.,
          Jones, R.L., and Roth, J.A. The laryngeal mask airway: A new standard for airway evaluation in thoracic
          surgery. Ann Thor Surg, 63:768 - 772, 1997.

*
    Resident / Fellow: Dr. Putnam served as mentor/faculty advisor
                                                                     - 13 -
Joe B. Putnam, Jr., M.D.                                                                      Rev: May 2010

Articles in Peer-Reviewed Journals (cont.)

      48. Walsh, G.L., Gokaslan, Z.L., McCutheon, I.E., Mineo, M.T., Yosko, A., Swisher, S.G., Schrump, D.S.,
          Nesbitt, J.C., Putnam, JB Jr., and Roth, J.A. Anterior approaches to the thoracic spine in patients with
          cancer: Indications and results. Ann Thor Surg, 64:1611 - 1618, 1997.
      49. Nesbitt, J.C., Soltero, E.R., Dinney, C.P.N., Walsh, G.L., Schrump, D.S., Swanson, D.A., Pisters, L.L.,
          Willis, K.D., and Putnam, JB Jr.. Surgical management of renal cell carcinoma with inferior vena cava
          tumor thrombus. Ann Thor Surg, 63:1592 - 1600, 1997.
      50. Perry, M.C., Deslauriers, J., Albain, K.S., Choi, N.C., Depierre, A., Johnston, M.R., et al. Induction
          treatment for resectable non - small - cell lung cancer. Lung Cancer 17: Suppl - 8: S15 - S18, 1997.
      51. Leukine Surgical Prophylaxis Research Group [Putnam, JB Jr., (P.I., UT M. D. Anderson Cancer Center].
          Randomized, placebo - controlled, multicenter trial of granulocyte - macrophage colony - stimulating factor
          as infection prophylaxis in oncologic surgery. J. Clin. Oncol. 16:1167 - 1173, 1998.
      52. Shin, D.M., Walsh, G.L., Komaki, R., Putnam, JB Jr., Nesbitt, J., Ro, J.Y., Shin, H.J., Ki, K.H., Wimberly,
          A., Pisters, K.M., Schrump, D., Gregurich, M.A., Cox, J.D., Roth, J.A., and Hong, W.K. A multidisciplinary
          approach to therapy for unresectable malignant thymoma. Ann. Intern. Med., 129:100 - 4, 1998.
      53. Gokaslan, Z.L., York, J.E., Walsh, G.L., McCutcheon, I.E., Lang, F.F., Putnam, JB Jr., Wildrick, D.M.,
          Swisher, S.G., Abi - Said, D., Sawaya, R. Transthoracic vertebrectomy for metastatic spinal tumors. J.
          Neurosurg., 89: 599 - 609, 1998.
      54. Roth, J.A., Atkinson, E.N., Fossella, F., Komaki, R., Ryan, M.B., Putnam, JB Jr., Lee, J.S., Dhingra, H., De
          Caro, L., Chasen, M., and Hong, W.K. Long - term follow - up of patients enrolled in a randomized trial
           comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIa non - small
          cell lung cancer. Lung Cancer, 21:1 - 6, 1998.
      55. Swisher, S.G., Nemunaitis, J., Timmons, T., Connors, D., Mack, M., Doerksen, L., Savin, M., Weill, D.,
          Shulkin, A., Wait, J., Ognoskie, N., Lawrence, D.D., Kemp, B.L., Fossella, F., Glisson, B.S., Hong, W.K.,
          Khuri, F.R., Kurie, J.M., Lee, J.J., Lee, J.S., Nguyen, D.M., Nesbitt, J.C., Perez - Soler, R., Pisters, K.M.W.,
          Putnam, JB Jr., Richli, W.R., Shin, M.D.M., Walsh, G., Merritt, J., and Roth, J.A. Adenovirus - mediated
          p53 gene transfer in advanced non - small cell lung cancer. J. Natl. Cancer Inst., 91: 763 - 771, 1999.
      56. Putnam, JB Jr., Light R.W., Rodriguez, R.M., Ponn, R., Olak, J., Pollak, J.S., and Lee, R.B. A randomized
          comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant
          pleural effusions. Cancer, 86:1992 - 9, 1999.
      57. Gandhi, S., Walsh, G.L., Komaki, R., Gokaslan, Z.L., Nesbitt, J.C., Putnam, JB Jr., Roth, J.A., Merriman,
          K.W., McCutcheon, I.E., Munden, R.F., and Swisher, S.G. A multidisciplinary surgical approach to superior
          sulcus tumors with vertebral invasion. Ann Thor Surg, 68:1778 - 84; discussion 1784 - 5, 1999.
      58. York, J.E., Walsh, G.L., Lang, F.F., Putnam, JB Jr., McCutcheon, I.E., Swisher, S.G., Komaki, R., and
          Gokaslan, Z.L. Combined chest wall resection with vertebrectomy and spinal reconstruction for the treatment
          of Pancoast tumors. J Neurosurg 91:74 - 80, 1999.
      59. Zebrowski, B.K. *, Yano, S., Liu, W., Hicklin, D.J., Putnam, JB Jr., and Ellis, L.M. Vascular endothelial
          growth factor levels and induction of permeability in malignant pleural effusions. Clin. Cancer Res., 5:3364 -
          68, 1999.
      60. Friedel G., Pastorino, U., Buyse, M., Ginsberg, R.J., Girard P., Goldstraw P. Putnam, JB Jr., et al.
          Resection of lung metastases: long - term results and prognostic analysis based on 5206 cases – the
          International Registry of Lung Metastases. (German). Zentralblatt fur Chirurgie, 124: 96 - 103, 1999.
      61. Medgyesy, D.C., Wolff, R.A., Putnam, JB Jr., and Ajani, J.A. Small cell carcinoma of the esophagus: The
          University of Texas M.D. Anderson Cancer Center Experience and Literature Review. Cancer, 88:262 - 267,
          2000.
      62. Putnam, JB Jr., Walsh, G.L., Swisher, S.G., Roth, J.A., Suell, D., Vaporciyan, A.A., Smythe, W.R.,
          Merriman, K.W., and DeFord, L.L. Outpatient management of malignant pleural effusion by a chronic
          indwelling pleural catheter. Ann Thor Surg, 69: :369 - 75, 2000.
      63. Pisters, K., Ginsberg, R., Giroux, D., Kris, M., Putnam, JB Jr., Roberts, J. R., Johnson, D. H., Crowley, J.,
          and Bunn, P. Induction chemotherapy before surgery for early stage lung cancer - A novel approach.
          Bimodality Lung Oncology Team, J Thor Cardiovasc Surg, 119:429 - 39, 2000.
      64. Nemunaitis, J., Swisher, S.G., Timmons, T., Connors, D., Mack, M., Doerksen, L., Weill, D., Wait, J.,
          Lawrence, D.D., Kemp, B.L., Fossella, F., Glisson, B.S., Hong, W.K., Khuri, F.R., Kurie, J.M., Lee, J.J., Lee,
          J.S., Nguyen, D.M., Nesbitt, J.C., Perez - Soler, R., Pisters, K.M.W., Putnam, JB Jr., Richli, W.R., Shin,
          D.M., Walsh, G.L., Merritt, J., and Roth, J.A. Adenovirus - mediated p53 gene transfer in sequence with
          cisplatin to tumors of patients with non - small cell lung cancer. J. Clin. Oncol., 18:609 - 622, 2000.

*
    Resident / Fellow: Dr. Putnam served as mentor/faculty advisor
                                                                     - 14 -
Joe B. Putnam, Jr., M.D.                                                                      Rev: May 2010

Articles in Peer-Reviewed Journals (cont.)

      65. Yen, N., Ioannides, C.G., Xu, K., Swisher, S.G., Lawrence, D.D., Kemp, B.L., El - Naggar, A.K., Cristiano,
          R.J., Fang, B., Glisson, B.S., Hong, W.K., Khuri, F.R., Kurie, J.M., Lee, J.J., Lee, J.S., Merritt, J.A.,
          Mukhopadhyay, T., Nesbitt, J.C., Nguyen, D., Perez - Soler, R., Pisters, K.M.W., Putnam, JB Jr., Schrump,
          D.S., Shin, D.M., Walsh, G.L., and Roth J.A. Cellular and humoral immune responses to adenovirus and p53
          protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild - type
          p53 (Ad - p53). Cancer Gene Therapy, 7: 530 - 536, 2000.
      66. Swisher, S.G., DeFord, L., Merriman, K.W., Walsh, G.L., Smythe, W.R., Vaporciyan, A.A., Ajani J.A.,
          Brown, T., Komaki, R., Roth, J.A., and Putnam, JB Jr.. Effect of operative volume on morbidity, mortality,
          and hospital use after esophagectomy for cancer. J Thor Cardiovasc Surg, 119:1126 - 1132, 2000.
      67. Komaki, R., Roth, JA Walsh, G.L., Putnam, JB Jr., Vaporciyan A, Lee JS, Fossella FV, Chasen M, Delclos
          ME, Cox JD. Outcome predictors for 143 patients with superior sulcus tumors treated by multidisciplinary
          approach at The University of Texas M. D. Anderson Cancer Center. Int. J. Radiat. Oncol. Biol. Phys., 2000
          Sep 1; 48(2): 347-54.
      68. Putnam, JB Jr., Thomsen, S.L., and Siegenthaler, M. Therapeutic implications of heat - induced lung injury:
          matching the energy source to the clinical need: Critical Review, 75:139 - 160, 2000.
      69. Walsh, G.L., Davis, B.M., Swisher, S.G., Vaporciyan, A.A., Smythe, W.R., Merriman, K.W., Roth, J.A., and
          Putnam, JB Jr. A single - institutional multidisciplinary approach to primary sarcomas involving the chest
          wall requiring full thickness resections. J. Thorac. Cardio. Surg., 121:48 - 60, 2001.
      70. Schnirer, I.I., Komaki, R., Yao, J.C., Swisher, S.G., Putnam, JB Jr., Pisters, P.W.T., Roth, J.A., and Ajani,
          J.A. A pilot study of concurrent 5 - fluorouracil/paclitaxel plus radiotherapy in patients with carcinoma of the
          esophagus and gastroesophageal junction. Am. J. Clinic. Oncol., 24:91 - 95, 2001.
      71. Smythe, W.R., Estrera, A.L., Swisher, S.G., Roth, J.A., Merriman, K.W., Walsh, G.L., Putnam, JB Jr.,
          Vaporciyan, A.A., and Roth, J.A. Surgical resection of non - small cell carcinoma following treatment for
          small cell carcinoma. Ann Thor Surg, 71:962 - 966, 2001.
      72. Siegenthaler, M.P. *, Pisters, K.M., Merriman, K.W., Swisher, S.G., Roth, J.A., Walsh, G.L., Vaporciyan,
          A.A., Smythe, W.R., and Putnam, JB Jr.. Preoperative chemotherapy for lung cancer does not increase
          surgical morbidity. Ann Thor Surg, 71:1105 - 1112, 2001.
      73. Walsh G.L., Davis, B.M., Swisher, S.G., Vaporciyan A.A., Smyth W.R., Willis - Merriman K., Roth J.A.,
          Putnam, JB Jr.. A single - institutional, multidisciplinary approach to primary sarcomas involving the chest
          wall requiring full - thickness resections. J Thorac Cardiovasc Surg 121: 48 - 60, January 2001.
      74. Ajani, J.A., Komaki, R., Putnam, JB Jr., Walsh, G., Nesbitt, J., Pisters, P.W., Lynch, P.M., Vaporciyan, A.,
          Smythe, R., Lahoti, S., Raijman I., Swisher, S., Martin, F.D., and Roth, J.A. A three - step strategy of
          induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable
          carcinoma of the esophagus or gastroesophageal junction. Cancer, 92:279 - 286, 2001.
      75. Hortobagyi, G.N., Ueno, N.T., Xia, W., Zhang, S., Wolf, J.K., Putnam, JB Jr., Weiden, P.L., Willey, J.S.,
          Carey, M., Branham, D.L., Payne, J.Y., Tucker, S.D., Bartholomeusz, C., Kilbourn, R.G., DeJager, R.L.,
          Sneige, N., Katz, R.L., Anklesaria, P., Ibrahim, N.K., Murray, J.L., Theriault, R.L., Valero, V., Gershenson,
          D.M., Bevers, M.W., Huang, L., Lopez - Berestein, G., and Hung, M.C. Cationic Liposome - mediated E1A
          gene transfer to human breast and ovarian cancer cells and its biological effects: A phase I clinical trial. J.
          Clin. Oncol., 19:3422 - 3433, 2001.
      76. Lewin, J.S., Hebert, T.M., Putnam, JB Jr., and DuBrow, R.A. Experience with the chin tuck maneuver in
          post esophagectomy aspirators. Dysphagia, 16:216 - 219, 2001.
      77. Komaki, R., Chasen, M.H., Travis, W.D., Putnam, JB Jr., Fossella, F.V., Byhardt, R.W., and Ro, J.Y.
          Oncodiagnosis panel: 1999, Cancer of the lung: Oncodiagnosis. Radiographics, 21:1573 - 1596, 2001.
      78. Wang, X., Wang. L., Callister, M.D., Putnam, JB Jr., Mao, L., and Li, L. Human Rad17 is phosphorylated
          upon DNA damage and also overexpressed in primary non - small cell lung cancer tissues. Cancer Res.,
          61:7417 - 7421, 2001.
      79. Vaporciyan, A.A., Merriman, K.W., Ece, F., Roth, J.A., Smythe, W.R., Swisher, S.G., Walsh, G.L., Nesbitt,
          J.C., and Putnam, JB Jr. Incidence of major pulmonary morbidity after pneumonectomy: association with
          timing of smoking cessation. Ann Thor Surg 73: 420 - 425, 2002.
      80. Rice, D.C., and Putnam, JB Jr. Recurrent bronchogenic cyst causing recurrent laryngeal nerve palsy. Eur. J.
          Cardiothorac. Surg., 21:561 - 563, 2002.
      81. Swisher, S.G., Wynn, P., Putnam, JB Jr., Mosheim, M.B., Correa, A.M., Komaki, R.R., Ajani, J.A.,
          Smythe, W.R., Vaporciyan, A.A., Roth, J.A., and Walsh, G.L. Salvage esophagectomy for recurrent tumors
          after definitive chemotherapy and radiotherapy. J Thor Cardiovasc Surg, 123:175 - 183, 2002.

*
    Resident / Fellow: Dr. Putnam served as mentor/faculty advisor
                                                                     - 15 -
Joe B. Putnam, Jr., M.D.                                                                    Rev: May 2010

Articles in Peer-Reviewed Journals (cont.)

   82. Vaporciyan, A.A., Rice, D.D., Correa, A.M., Walsh, G.L., Putnam, JB Jr., Swisher, S.G., Smythe, W.R.,
       and Roth, J.A. Resection of advanced thoracic malignancies requiring cardiopulmonary bypass. Eur. J.
       Cardiothorac. Surg., 22:47 - 52, 2002.
   83. Bubb, R.S., Komaki, R., Hachiya, T., Milas, I., Ro, J.Y., Langford, L., Sawaya, R., Putnam, JB Jr., Allen,
       P., Cox, J.D., McDonnell, T.J., Brock, W., Hong, W.K., Roth, J.A., and Milas, L. Association of Ki - 67,
       p53, and bcl - 2 expression of the primary non - small cell lung cancer lesion with brain metastatic lesion. Int.
       J. Radiat. Oncol. Biol. Phys., 53: 1216 - 1224, 2002.
   84. Friedel, G., Pastorino, U., Ginsberg, R. J., Goldstraw, P., Johnston, M., Pass, H., Putnam, J. B., Toomes, H.,
       and International Registry of Lung Metastases, London England. Results of lung metastasectomy from breast
       cancer: prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases.
       European Journal of Cardio - Thoracic Surgery. 22:335 - 344. 2002.
   85. Hofstetter, W., Swisher, S.G., Correa, A.M., Hess, K., Putnam, JB Jr., Ajani, J.A., Dolormente, M.,
       Francisco, R., Komaki, R.R., Martin, L.A., Rice, D.C., Sarabia, A.J., Smythe, W.R., Vaporciyan, A.A.,
       Walsh, G.L., and Roth, J.A. Treatment outcomes of resected esophageal cancer. Ann. Surg., 236:376 - 384;
       discussion 384 - 385, 2002.
   86. Swisher, S. G., Roth, J. A., Komaki, R., Gu, J., Lee, J. J., Hicks, M., RO, J. Y., Hong, W. K., Merritt, J. A.,
       Ahrar, K., Atkinson, N. E., Correa, A. M., Dolormente, M., Dreiling, L., el Naggar, A. K., Fossella, F.,
       Francisco, R., Glisson, B., Grammer, S., Herbst, R., Huaringa, A., Kemp, B., Khuri, F. R., Kurie, J. M., Liao,
       Z., McDonnell, T. J., Morice, R., Morello, F., Munden, R., Papadimitrakopoulou, V., Pisters, K. M., Putnam,
       J. B., Jr., Sarabia, A. J., Shelton, T., Stevens, C., Shin, D. M., Smythe, W. R., Vaporciyan, A. A., Walsh, G.
       L., and Yin, M. Induction of p53 - regulated genes and tumor regression in lung cancer patients after
       intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy. Clinical Cancer Research. 9[1],
       93 - 101. 2003.
   87. Swisher, S. G., Ajani, J. A., Komaki, R., Nesbitt, J. C., Correa, A. M., Cox, J. D., Lahoti, S., Martin, F.,
       Putnam, J. B., Smythe, W. R., Vaporciyan, A. A., Walsh, G. L., and Roth, J. A. Long - term outcome of
       phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced
       esophageal cancer. International Journal of Radiation Oncology, Biology, and Physics. 57: 120 - 127, 2003.
   88. Sabloff B, Munden RF, Melhem AI, el Naggar AK, Putnam, JB Jr., Jr. Radiologic - pathologic conferences
       of University of Texas M. D. Anderson Cancer Center: Extraskeletal osteosarcoma of the pleura. American
       Journal of Roentgenology, 180:972, 2003.
   89. Rice, D., Kim, H. W., Sabichi, A., Lippman, S., Lee, J. J., Williams, B., Vaporciyan, A., Smythe, W. R.,
       Swisher, S., Walsh, G., Putnam, J. B., Jr., Hong, W. K., and Roth, J. The risk of second primary tumors
       after resection of stage I non - small cell lung cancer. Annals of Thoracic Surgery, 76:1001 - 1007, 2003.
   90. Milas, I., Komaki, R., Hachiya, T., Bubb, R. S., Ro, J. Y., Langford, L., Sawaya, R., Putnam, J. B., Allen, P.,
       Cox, J. D., McDonnell, T. J., Brock, W., Hong, W. K., Roth, J. A., and Milas, L. Epidermal growth factor
       receptor, cyclooxygenase - 2, and BAX expression in the primary non - small cell lung cancer and brain
       metastases. Clinical Cancer Research 9:1070 - 1076, 2003.
   91. Sweeney, P., Wood, C.G., Pisters, L.L., Slaton, J.W., Vaporciyan A., Munsell, M., Putnam, J.B. Jr.
       Surgical management of renal cell carcinoma associated with complex inferior vena caval thrombi. Urologic
       Oncology 21: 327 - 33, 2003.
   92. Lee, H. K., Vaporciyan, A. A., Cox, J. D., Tucker, S. L., Putnam, J. B., Jr., Ajani, J. A., Liao, Z., Swisher,
       S. G., Roth, J. A., Smythe, W. R., Walsh, G. L., Mohan, R., Liu, H. H., Mooring, D., and Komaki, R.
       Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma:
       correlation with pulmonary dose - volume histogram parameters. International Journal of Radiation
       Oncology, Biology, Physics 57:1317 - 1322, 2003.
   93. Tsao AS, McDonnell T, Lam S, Putnam, JB Jr., Bekele N, Hong WK, Kurie JM. Increased phospho - AKT
       (Ser 473) expression in bronchial dysplasia: implications for lung cancer prevention studies. Cancer
       Epidemiol Biomarkers Prev. Jul; 12:660 - 4, 2003.
   94. Taylor NA, Liao ZX, Stevens C, Walsh G, Roth J, Putnam JB Jr, Fossella F, Allen P, Cox JD, Komaki R.
       Postoperative radiotherapy increases locoregional control of patients with stage IIIA non - small - cell lung
       cancer treated with induction chemotherapy followed by surgery. Int J Radiat Oncol Biol Phys. 56:616 - 25,
       2003.
   95. Sweeney P, Wood CG, Pisters LL, Slaton JW, Vaporciyan A, Munsell M, Carpenter S, Putnam, JB Jr.,
       Swisher SG, Walsh G, Swanson D, Dinney CP. Surgical management of renal cell carcinoma associated with
       complex inferior vena caval thrombi. Urol Oncol. 21:327 - 33, 2003.
   96. Eberhardt WE, Albain KS, Pass H, Putnam, JB Jr., Gregor A, Asamura H, Mornex F, Senan S, Belderbos J,
       Westeel V, Thomas M, Van Schil P, Vansteenkiste J, Manegold C, Mirimanoff RO, Stuschke M, Pignon J,
                                                           - 16 -
Joe B. Putnam, Jr., M.D.                                                                       Rev: May 2010

   Articles in Peer-Reviewed Journals (cont.)

         Rocmans P, Shepard FA. Induction treatment before surgery for non - small cell lung cancer. Lung Cancer.
         2003 Dec; 42 Suppl 1: S9 - 14 Review.
   97.   Taylor NA, Liao ZX, Cox JD, Stevens C, Roth J, Walsh G, Chang JY, Guerrero T, Jeter M, Putnam J Jr.,
         Fossella FV, Allen P, Komaki R. Equivalent outcome of patients with clinical stage IIIA non - small - cell
         lung cancer treated with concurrent chemoradiation compared with induction chemotherapy followed by
         surgical resection. Int J Radiat Oncol Biol Phys. 58: 204 - 12, 2004.
   98.   Onn A, Correa Am, Gilcrease M, Isobe T, Massarelli E, Bucanna CD, O‟Reilly MS, Hong WK, Fidler IJ,
         Putnam, JB Jr., Herbst RS. Synchronous overexpression of epidermal growth factor receptor and HER2 -
         neu protein is a predictor of poor outcome in patients with state I non - small cell lung cancer. Clin Cancer
         Res. 10: 136 - 43, 2004.
   99.   Vaporciyan AA, Putnam, JB Jr., Smythe WR. The potential role of aprotinin in the perioperative
         management of malignant tumors. J Am Coll Surg. 198: 266 - 78, 2004.
  100.   Vaporciyan AA, Correa AM, Rice DC, Roth JA, Smythe WR, Swisher SG, Walsh GL, Putnam, JB Jr., Risk
         factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients. J Thorac
         Cardiovasc Surg. 127:779 - 86, 2004.
  101.   Ajani JA, Walsh G, Komaki R, Morris J, Swisher SG, Putnam, JB Jr., Lynch PM, Wu TT, Smythe WR,
         Vaporciyan A, Faust J, Cohen DS, Nivers R, Roth JA. Preoperative induction of CPT - 11 and cisplatin
         chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or
         gastroesophageal junction. Cancer 100:2347 - 54, 2004.
  102.   Agarwal B, Swisher S, Ajani J, Kelly K, Fanning C, Komaki RR, Putnam, JB Jr., Abu - Hamda E, Molke
         KL, Walsh GL, Correa AM, Ho L, Liao Z, Lynch PM, Rice DC, Smythe WR, Stevens CW, Vaporciyan AA,
         Yao J, Roth JA. Endoscopic ultrasound after preoperative chemoradiation can help identify patients who
         benefit maximally after surgical esophageal resection. Am J Gastroenterol. 99:1258 - 66, 2004.
  103.   Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A,
         Putnam, JB Jr., Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R. Induction chemotherapy
         improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed
         by surgery. Int. J Radiat Oncol Biol Phy 60: 427 - 36, 2004.
  103.   Swisher SG, Eramus J, Maish M, Correa AM, Macapinlac H, Ajani JA, Cox JD, Komaki RR, Hong D, Lee
         HK, Putnam, JB Jr., Rice DC, Smythe WR, Thai L, Vaporciyan AA, Walsh GL, Wu TT, Roth JA. 2 -
         Fluoro - 2 - deoxy - D - glucose positron emission tomography imaging is predictive of pathologic response
         and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer. 101:1776 - 85,
         2004.
  104.   Vaporciyan, A.A., Merriman, K.W., Ece, F., Roth, J.A., Smythe, W.R., Swisher, S.G., Walsh, G.L., Nesbitt,
         J.C., and Putnam, JB Jr. Utility of PET, CT and EUS to identify pathologic responders in esophageal
         cancer. Ann Thor Surg, 78:1152 - 60, 2004.
  105.   Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Steven SW, Ho L, Smythe R, Vaporciyan AA, Putnam, JB
         Jr., Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R. Esophagectomy after concurrent
         chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Int J
         Radiat Oncol Biol Phys. 60:1484 - 93, 2004.
  106.   Newman, L.A., Hurd, T., Leitch, M., Kuerer, H.M., Diehl, K., Lucci, A., Putnam, JB Jr., et al. A report on
         accrual rates for elderly and minority - ethnicity cancer patients to clinical trials of the American College of
         Surgeons Oncology Group. J Am Coll Surgeons 4: 644 - 51, 2004.
  107.   Swisher, S.G., Maish, M., Erasmus, J.J., Correa, A.M., Ajani, J.A., Bresalier, R., Putnam, JB Jr. Utility of
         PET, CT and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg 78: 1152 - 60,
         2004.
  108.   Kim ES, Putnam, JB Jr., Jr., Komaki R, Walsh GL, Ro JY, Shin HJ, Truong M, Moon H, Swisher SG,
         Fossella FV, Khuri FR, Hong WK, Shin DM. Phase II study of a multidisciplinary approach with induction
         chemotherapy, followed by surgical resection, radiation therapy and consolidation chemotherapy for
         unresectable malignant thymomas: final report. Lung Cancer. 44:369 - 79, 2005.
  109.   Rice DC, Correa AM, Vaporciyan AA, Sodhi N, Smythe WR, Swisher SG, Walsh GL, Putnam, JB Jr.,
         Komaki R, Ajani JA, Roth JA. Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is
         not associated with increased morbidity. Ann Thor Surg; 79:391 - 7, 2005.
  110.   Sasaki R, Komaki R, Macapinlac H, Erasmus J, Allen P, Forster K, Putnam, JB Jr., Herbst RS, Moran CA,
         Podoloff DA, Roth JA, Cox JD. [18F] fluorodeoxyglucose uptake by positron emission tomography predicts
         outcome of non - small - cell lung cancer. J Clin Oncol. 23:1136 - 43, 2005.



                                                             - 17 -
Joe B. Putnam, Jr., M.D.                                                                  Rev: May 2010

Articles in Peer-Reviewed Journals (cont.)

  111. Shaw AD, Vaporciyan AA, Wu X, King TM, Spitz MR, Putnam, JB Jr., Dickey BF. Inflammatory gene
       polymorphisms influence risk of postoperative morbidity after lung resection. Ann Thor Surg. 2005 May; 79:
       1704 - 10.
  112. Gaspar, LE, Gay EG, Crawford J, Putnam JB Jr, Herbst RS, Bonner JA. Limited - stage small - cell lung
       cancer (Stages (I - III): Observations from the National Cancer Database. Clin Lung Cancer. 2005 May; 6:
       355 - 60.
  113. Ascioti AJ, Hofstetter WL, Miller MJ, Rice DC, Swisher SG, Vaporciyan AA, Roth JA, Putnam, JB Jr,
       Smythe WR, Feig BW, Mansfield PF, Pisters PW, Torres MT, Walsh GL. Long - segment, supercharged,
       pedicled jejunal flap for total esophageal reconstruction. J Thor Cardiovasc Surg 2005 Nov; 130:1391 - 8.
  114. Martin LW, Correa AM, Hofstetter W, Hong WK, Komaki R, Putnam JB, Jr., Rice DC, Smythe WR,
       Swisher SG, Vaporciyan AA, Walsh GL, Roth JA. The evolution of treatment outcomes for resected stage
       IIIA non - small cell lung cancer over 16 years at a single institution. J Thor Cardiovasc Surg 130:1601 - 10,
       2005.
  115. Allen MS, Darling GE, Pechet TT, Mitchell JD, Herndon JE, Landreneau RJ, Inculet RI, Jones DR, Meyers
       BF, Harpole DH, Putnam JB, Jr., Rusch VW, and ACOSOG Z0030 Study Group. Morbidity and mortality
       of major pulmonary resections in patients with early - stage lung cancer: initial results of the randomized,
       prospective ACOSOG Z0030 trial. Ann Thor Surg; 81: 1013 - 1020, 2006.
  116. Posther, K.E., McCall, L.M., Harpole, D.H., Jr., Reed, C.E., Putnam JB Jr., Rusch, V.W., et al. Yield of
       brain 18F - FDG PET in evaluating patients with potentially operable non - small cell lung cancer. Journal of
       Nuclear Medicine 47: 1607 - 11, 2006.
  117. Albert, JM, Gonzalez, A, Massion, PP, Chen, H, Olson, SJ, Shyr, Y, Diaz, R, Lambright, ES, Sandler, A,
       Carbone, DP, Putnam, JB Jr., Johnson, DH, Lu, B. Cytoplasmic Clusterin Expression is Associated with
       Longer Survival in Patients with Resected Non - Small Cell Lung Cancer. Cancer Epidemiol Biomarkers
       Prev 2007; 16, 1845 - 51, 2007.
  118. Bakaeen, F., Rice, D., Correa, A.M., Walsh, G.L., Vaporciyan, A.A., Putnam, J.B. Jr., et al. Use of
       aprotinin in extrapleural pneumonectomy: effect on hemostasis and incidence of complications. Ann Thorac
       Surg 84: 982 - 986, 2007.
  119. Horn, L., Sandler, A.B., Putnam, J.B., Jr., Johnson, D.H. The rationale for adjuvant chemotherapy in stage I
       non - small cell lung cancer. Journal of Thoracic Oncology: Official Publication of the International
       Association for the Study of Lung Cancer 2: 377 - 383, 2007.
  121. Meyers, BF, Downey, RJ, Decker, PA, Keenan, RJ, Siegel, BA, Cerfolio, RJ, Landreneau, RJ, Reed, CE,
       Balfe, DM, Dehdashti, F, Ballman, KV, Rusch, VW, Putnam, JB Jr. The utility of positron emission
       tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American
       College of Surgeons Oncology Group Z0060 trial. J Thorac Cardiovasc Surg 133: 738 - 745, 2007.
  122. Kozower BD, Meyers CG, Reed CE, Jones DR, Decker PA, Putnam JB Jr. Does positron emission
       tomography prevent Nontherapeutic pulmonary resections for clinical stage IA lung cancer? Ann Thorac
       Surg; 85: 1166 – 1169 (discussion 1169 – 1170), 2008.
  123. Veeramachaneni NK, Zoole JB, Decker PA, Putnam JB, Jr., Meyers BF, American College of Surgeons
       Oncology Group. Lymph node analysis in esophageal resection: American College of Surgeons Oncology
       Group Z0060 trial. Annals of Thoracic Surgery 421 20; 86(2):418-21.
  124. Wakelee H. Kernstine K. Vokes E. Schiller J. Baas P. Saijo N. Adjei A. Goss G. Gaspar L. Gandara DR.
       Choy H. Putnam JB Jr. Cooperative group research efforts in lung cancer 2008: focus on advanced-stage
       non-small-cell lung cancer. Clinical Lung Cancer 2008 Nov; 9(6):346-51.
  125. Blackmon SH. Rice DC. Correa AM. Mehran R. Putnam JB Jr. Smythe WR. Walkes JC. Walsh GL. Moran
       C. Singh H. Vaporciyan AA. Reardon M. Management of primary pulmonary artery sarcomas. Annals of
       Thoracic Surgery 2009 Mar; 87(3):977-84.
  126. Wakelee H, Loo BWJr, Kernstine KH, Putnam JBJr., Edelman MJ, Vokes EE, Schiller JH, Baas P, Saijo N,
       Adjei A, Goss G, Choy H, Gandara DR. Cooperative Group Research Efforts in Thoracic Malignancies
       2009: A Review From the 10th Annual International Lung Cancer Congress. Clinical Lung Cancer 2009
       Nov; 395-404.
  127. Pisters KMW, Vallieres E, Crowley JJ, Franklin WA, Bunn PA, Ginsberg RJ; Putnam JBJr, Chansky K,
       Gandara DR. Surgery With or Without Preoperative Paclitaxel and Carboplatin in Early-Stage Non-Small
       Cell Lung Cancer: Southwest Oncology Group Trial S9900, an Intergroup, Randomized, Phase III Trial.
       Accepted: Journal of Clinical Oncology, 2010.




                                                          - 18 -
Joe B. Putnam, Jr., M.D.                                                                  Rev: May 2010

  Invited Articles:

    1.     Putnam JB Jr., and Roth, JA. Prognostic indicators in patients with pulmonary metastases. N. Martini (ed.),
           Semin. Surg. Oncol., 6:291 - 296, 1990.
    1.    Putnam JB Jr., Akiyama, H. Surgery for cancer of the esophagus. Publishers Williams and Wilkins; reviewed
          for Cancer Bulletin 43:283, 1991.
    2.    Putnam JB Jr, Sanders, R.J., and Haug, C.E. Thoracic Outlet Syndrome, Lippincott, reviewed for Mil. Med.,
          157:A7, 1992.
    3.    Putnam, JB Jr., Richter, J.E. (ed.), Ambulatory Esophageal Ph Monitoring: Practical Approach and Clinical
          Applications, reviewed for Mil. Med., 158:A9, 1992.
    4.    Lanza, L.A., Natarajan, G., Roth, J.A., and Putnam, JB Jr., Long - term survival following pulmonary
          metastases from carcinoma of the breast. Clinical Digest Series Respir Diseases Digest, 2:16, 1993.
    5.    Putnam, JB Jr., Surgery for stage N2 lung cancer. Semin. Thorac. Cardiovasc. Surg., 5:249 - 257, 1993.
    6.    Putnam, JB Jr., Suell, D.M., Natarajan, G., Roth, J.A. Extended resection of pulmonary metastases: Is the risk
          justified? Ann Thorac Surg 55: 1440 - 6, 1993.
    7.    Gorenstein, L.A., Putnam, JB Jr., Balch, C.A., and Roth, J.A. Improved survival following resection of
          pulmonary metastases from malignant melanoma. Sel. Read Gen. Surg., 1993.
    8.    Putnam, JB Jr., and Roth, J.A. Resection of sarcomatous pulmonary metastases. Surg Oncol Clin N Am., 2:673
          - 691, 1993.
    9.    Putnam, JB Jr., Prakash, U.B.S. (ed.), Bronchoscopy, Reviewed for Cancer Bulletin, 1994.
    10.   Roth, J.A., and Putnam, JB Jr., Surgery for cancer of the esophagus. Semin. Oncol. 21:453 - 461, 1994.
    11.   Putnam, JB Jr., and Roth, J.A. Surgical treatment for pulmonary metastases from sarcoma. Hematol Oncol Clin
          North Am, 9:869 - 887, 1995.
    12.   Swisher, S.G., Roth, J.A., and Putnam, JB Jr., Diagnosis and Management of Benign Esophageal Tumors.
          Cancer Bull., 47:396 - 401, 1995.
    13.   Walsh, G.L., Morice, R.C., Putnam, JB Jr., Nesbitt, J.C., McMurtrey, M.J., Reising, J., Willis, K.M., Morton,
          J.D., and Roth, J.A. Resection of lung cancer is justified in high - risk patients selected by exercise oxygen
          consumption. In: R.J. Ginsberg, A.S. Wechsler, and W.G. Williams (eds.), The Year Book of Thoracic and
          Cardiovascular Surgery, pp 5 - 7, Chicago, IL., Mosby - Year Book, Inc., 1996.
    14.   Lanza, L.A., Natarajan, G., Roth, J.A., and Putnam, JB Jr., Long - term survival following pulmonary
          metastases from carcinoma of the breast. Sel. Read Gen. Surg., 1996.
    15.   Komaki, R., Putnam, JB Jr., Shin, D.M., and Cox, J.D. Thymic neoplasms. Curr. Opin. Oncol., 9:156 - 160,
          1997.
    16.   Roth, J.A., Nguyen, D., Lawrence, D.D., Kemp, B.L., Carrasco, C.H., Ferson, D.Z., Hong, W.K., Komaki, R.,
          Lee, J.J, Nesbitt, J.C., Pisters, K.M.W., Putnam, JB Jr., Shea, R., Shin, D.M., Walsh, G.L., Dolormente, M.M.,
          Han, C - I., Martin, F.D., Yen, N., Stephens, L.C., McDonnell, T.J., Mukhopadhyay, T., and Cai, D. Retrovirus -
          mediated wild - type p53 gene transfer to tumors of patients with lung cancer. Medical Briefs in Cancer, 2:4 - 5,
          1997.
    17.   Roth, J.A., Swisher, S.G., Merritt, J.A., Lawrence, D.D., Kemp, B.L., Cesar H.C., El - Naggar, A.K., Fossella,
          F.V., Glisson, B.S., Hong, W.K., Khuri, F.R., Kurie, J.M., Nesbitt, J.C., Pisters, K., Putnam, JB Jr., Schrump,
          D.S., Shin, D.M., and Walsh, G.L. Gene therapy for non - small cell lung cancer: A preliminary report of a phase
          I trial of adenoviral p53 gene replacement. Semin. Oncol. 25:33 - 37, 1998.
    18.   Putnam, JB Jr., Complications of multimodality therapy. Chest Surg Clin N Am, 8: 663 - 680, 1998.
    19.   Putnam, JB Jr., Soft part sarcomas – metastases. Chest Surg Clin N Amer., 8:97 - 118, 1998.
    20.   Komaki, R., Putnam, JB Jr., Walsh, G., Lee, J.S., and Cox, J.D. The management of superior sulcus tumors.
          Sem. Surg. Oncol., 18:152 - 164, 2000.
    21.   Putnam, JB Jr., Lung cancer. Semin. Surg. Oncol., 18:89 - 90, 2000.
    22.   Komaki, R., Cox, J.D., Putnam, JB Jr., Walsh, G., Vaporciyan, A., Liao, Z., Stevens, C., Fossella, F.V., Lee,
          J.S., Hong, W.K., and Roth, J.A. The management of superior sulcus tumors, J Japanese Soc Ther Radiol Oncol,
          13:131 - 138, 2001.
    23.   Putnam, JB Jr., The anatomic basis for lung cancer staging: the end of the beginning? Ann Thorac. Surg., 71:1757 -
          1758, 2001.
    24.   Putnam, JB Jr., New and evolving treatment methods for pulmonary metastases. Semin. Thorac. Cardiovasc.
          Surg., 14:49 - 56, 2002.
    25.   Putnam, Jr., J. B., Malignant pleural effusions. Surgical Clinics of North America. 82:867 - 883, 2002.
    26.   Ajani, J. A., Faust, J., Yao, J., Komaki, R., Stevens, C., Swisher, S., Putnam, Jr., J. B., Vaporciyan, A., Smythe,
          R., Walsh, G., Rice, D., and Roth, J. Irinotecan/cisplatin followed by 5 - FU/paclitaxel/radiotherapy and surgery
          in esophageal cancer. Oncology (Williston Park). 17(9: Suppl 8), 2003.

                                                           - 19 -
Joe B. Putnam, Jr., M.D.                                                                    Rev: May 2010

         Invited Articles (cont.):

    27. Eberhardt WE, Albain KS, Pass H, Putnam, JB Jr., Gregor A, Asamura H, Mornex F, Senan S, Belderbos J,
        Westeel V, Thomas M, Van Schil P, Vansteenkiste J, Manegold C, Mirimanoff RO, Stuschke M, Pignon J,
        Rocmans P, Shepherd FA. Induction treatment before surgery for non - small cell lung cancer. Lung Cancer 42,
        Suppl. 1:S9 - S14, 2003.
    28. Putnam, JB Jr., Royston D, Chambers AF, Dunbar S, Lemmer JH, Norman P, Travis E, Vaporciyan AA, Yang
        S, Zacharski LR. Evaluating the role of serine protease inhibition in the management of tumor micrometastases.
        Oncology (Williston Park) 17 (10 Suppl 10): Suppl - 30.
    29. Ajani JA, Faust J, Yao J, Komaki R, Stevens C, Swisher S, Putnam, JB Jr., Vaporciyan A, Smythe R, Walsh G,
        Rice D, Roth J. Irinotecan/cisplatin followed by 5 - FU/paclitaxel/radiotherapy and surgery in esophageal cancer.
        Oncology (Williston Park). 2003 Sep; 17(9 Suppl 8):20 - 2.
    30. Putnam, JB Jr. Quality Improvement in Thoracic Surgery. Japanese Journal of Lung Cancer, Vol. 44, October
        2004.
    31. Putnam, JB Jr. Is Resection Necessary for Esophageal Carcinoma? Semin Oncol, 32(6 Suppl 9), S21 - 4, 2005.
    32. Oh Y, Mohiuddin I, Sun Y, Putnam JB, Jr., Hong WK, Arap W, Pasqualini R. Phenotypic diversity of the lung
        vasculature in experimental models of metastases. . Chest 2005 Dec; 128(6: Suppl):Suppl - 600S.
    33. You, YN, Hunt, KK, Posner, MC, Putnam, JB, Jr., Nelson, H, Ota, DM. Surgical Research Review: Operative
        trials: the opportunity beckons – an update on the American College of Surgeons Oncology Group. Surgery
        139:4, 455 - 459, 2006.
    34. Putnam, JB Jr., Invited commentary: Ann Thorac Surg 83: 424, 2007.
    35. Antevil, JL, Putnam, JB Jr., Talc Pleurodesis for Malignant Effusions is Preferred over the PleurX Catheter (Pro
        Position). Annals of Surgical Oncology; 14: 2698 - 2699, 2007.

    Editorials and Other Articles

    1.     Putnam, JB Jr., Palliation of central airway stenoses with the Dumon silicone stent. Editorial on Bolliger CT,
           Probst R, Tschopp K, Soler M, Perruchoud AP: Silicone stents in the management of inoperable
           tracheobronchial stenoses: Indications, limitations. Chest, 104:1651 - 1652, 1993.
    2.     Benjamin, R.S., and Putnam, JB Jr., Another half step. Ann Thor Surg, 1995.
    3.     Putnam, JB Jr., The anatomic basis for lung cancer staging: the end of the beginning?, Ann Thor Surg, 71:1757
          - 58, 2001.
    4.     Gaissert HA, Casale AS, Creswell LL, Ferguson TB Jr., Fullerton DA, Kernstine KH, McMullan DM, Ring WS,
           Putnam, JB Jr., (Society of Thoracic Surgeons Workforce on Clinical Trials). Mentoring clinical trials in
          thoracic and cardiovascular surgery: a new role for the Society of Thoracic Surgeons. Ann Thor Surg. 77: 1874 -
          5, 2004.
    5.    You YN, Hunt KK, Posner MC, Putnam, JB Jr., Nelson H, Ota DM, Pisters PWT. Surgical Trials: The
          Opportunity Beckons-An Update of the American College of Surgeons Oncology Group. Surgery2006 139:455-9.
    6.    Putnam, JB Jr., Results of chest wall resection and reconstruction with and without rigid prosthesis (Invited
          Commentary). Ann. Thorac Surg, 2006; 81: 285.
    7.    Putnam, JB Jr. Preoperative Serum Carcinoembryonic Antigen Level is a Prognostic Factor in Females with
          Early Non - small Cell Lung Cancer (Invited Commentary), Ann of Thorac Surg, 2007; 83:424.

    Abstracts

    1.    Ferson, D.Z., Nesbitt, J.C., Walsh, G.L., Putnam, JB Jr., Schrump, D.S., Nesbitt, K.K., Jones, R.L., Johansen,
          M.J., Jones, R.L., and Roth, J.A. The laryngeal mask airway: A new standard for airway evaluation in thoracic
          surgery. Society of Thoracic Surgeons Annual Meeting, San Diego, CA, Proc. Soc. Thorac. Surg., 1997.
    2.    Gokaslan, Z.L., McCutcheon, I.E., Walsh, G.L., Putnam, JB Jr., and Nesbitt, J.C. Transthoracic vertebrectomy
          in cancer patients. Association‟s Annual Meeting of the American Association of Neurological Surgeons,
          Denver, Colorado, 1997.
    3.    Benjamin, R.S., Putnam, JB Jr., Tran, H.T., Hager, H.K., and Madden, T. High levels of doxorubicin in human
          lung and pulmonary metastases following single - pass isolated - single - lung perfusion. American Association
          Cancer Research Annual Meeting, San Diego, CA, Pro. Am. Assoc. Cancer Res., 1997.
    4.    Swisher, S.G., Roth, J.A., Lawrence, D., Kemp, B., Carrasco, C., Fossella, F., Glisson, B., Hong, W.K., Khuri, F.,
          Kurie, J., Nesbitt, J.C., Pisters, K., Putnam, JB Jr., Schrump, D., Shin, D., and Walsh, G.L. Adenoviral
          medicated p53 gene transfer in patients with advanced non - small cell lung cancer (NSCLC). Proc. Am. Soc.
          Clin Oncol., Denver, Colorado, 1997.

                                                            - 20 -
Joe B. Putnam, Jr., M.D.                                                                       Rev: May 2010

    Abstracts (cont.)

    5.    Shin, D.M., Komaki, R., Putnam, JB Jr., Walsh, G.L., Nesbitt, J.C., Ro, Y., Schea, D., Schrump, D.S., Cox,
          J.D., Roth, J.A., and Hong, W.K. Induction chemotherapy (IC) followed by surgical resection (SR), stages of
          unresectable invasive thymoma. Proc. Am. Soc. Clin. Oncol., Denver, Colorado, 1997.
    6.    Putnam, JB Jr., Madden, T., Tran, H.T, Benjamin, R.S. Isolated single lung perfusion (ISLP) with adriamycin
          for unresectable sarcomatous metastases. Proc ASCO 16 [#1799], 500a. 1997.
    7.    Shin, D.M., Komaki, R., Putnam, JB Jr., Walsh, G.L., Nesbitt, J.C., Ro, Y., Schea, R.A., Pisters, K.M.W.,
          Schrump, D., Gregurich, M.A., Cox, J.D., Roth, J.A., and Hong, W.K. Multidisciplinary approach of therapy for
          advanced stages of unresectable invasive thymoma. 1 st International Meeting on Advances in the Knowledge of
          Cancer Management, UICC, Vienna, Austria, 1997.
    8.    Roth, J.A., Swisher, S.G., Lawrence, D.D., Kemp, B.L., Carrasco, C.H., El - Naggar, A.K., Fossella, F.V.,
          Glisson, B.S., Hong, W.K., Khuri, F.R., Kurie, J.C., Nesbitt, J.C., Pisters, K., Putnam, JB Jr., Schrump, D.S.,
          Shin, D.M., and Walsh, G.L. Department of Thoracic and Cardiovascular Surgery, University of Texas M. D.
          Anderson Cancer Center, Houston, Texas, USA, Gene Replacement for Lung Cancer. 8 th World Conference on
          Lung Cancer, Journal of the International Association for the Study of Lung Cancer, 18:76, Dublin, Ireland, 1997.
    9.    Roth, J.A., Swisher, S.G., Lawrence, D.D., Kemp, B.L., Carrasco, C.H., El - Naggar, A.K., Fossella, F.V,,
          Glisson, B.S., Hong, W.K., Khuri, F.R., Kurie, J.C., Nesbitt, J.C., Pisters, K., Putnam, JB Jr., Schrump, D.S.,
          Shin, D.M., and Walsh, G.L. Department of Thoracic and Cardiovascular Surgery, University of Texas M. D.
          Anderson Cancer Center, Houston, Texas, USA, Gene Therapy Strategies for Lung Cancer. 8th World Conference
          on Lung Cancer, Journal of the International Association for the Study of Lung Cancer, 18:141, Dublin, Ireland,
          1997.
    10.   Shin, D.M., Komaki, R., Putnam, JB Jr., Walsh, G.L., Nesbitt, J.C., Ro, J.Y., Schea, R.A., Pisters, K.W.M.,
          Schrump, D.S., Gregurich, M.A., Cox, J.D., Roth, J.A., and Hong, W.K. Induction chemotherapy (C) followed by
          surgical resection (SR), radiotherapy (RT), and consolidative chemotherapy (CC) may cure the advanced stages of
          unresectable thymoma. American Society of Clinical Oncology Annual Meeting, Denver, CO, Proc. Am. Soc.
          Clin. Oncol., 1997.
    11.   Nesbitt, J.C., Ferson, D.Z., Walsh, G.L., Schrump, D.S., Swisher, S.G., Nesbitt, K.K., and Putnam, JB Jr., The
          laryngeal mask airway and laser bronchoscopy for tumors of the tracheobronchial tree. Southern Thoracic
          Surgical Association Annual Meeting, Chicago, IL, 1997.
    12.    Nesbitt, J.C., Whitehead, W.E., Darwish, A.A., Walsh, G.L., Schrump, D.S., Swisher, S.G., Willis, K.D., Roth,
          J.A., and Putnam, JB. Survival and operative risk following pneumonectomy. American College of Chest
          Physicians Chest ‟97 Meeting, New Orleans, LA, 1997.
    12.   Nesbitt, J.C., Ferson, D.Z., Walsh, G.L., Schrump, D.S., Swisher, S.G., Nesbitt, K.K., and Putnam, JB Jr., The
          laryngeal mask airway: A valuable adjunct for laser bronchoscopy of obstructive tumors. American College of
          Chest Physicians Chest ‟97 Meeting, New Orleans, LA, 1997.
    13.   Putnam, JB Jr., Ponn, R., Olak, J., Pollak, J., Lee, R.B., Light, R., Alonso, A., Payne, D.K., Graeber, G., Kovitz,
          K., Brown, B., and Rodriguez, M. Pleural Catheter Study Group: A phase III trial of treatment for malignant
          pleural effusions: Pleurx® pleural catheter (PC) versus chest tube + doxycycline sclerosis (CT - S). American
          College of Chest Physicians Chest ‟97 Meeting, New Orleans, LA, 1997.
    14.   Putnam, JB Jr., Madden, T., Tran, H.T., and Benjamin, R.S. Isolated single lung perfusion (ISLPP) with
          Adriamycin for unresectable sarcomatous metastases. Connective Tissue Oncology Society, Milan, Italy, 1997.
    15.   Swisher, S.G., Hu, M., Holmes, E.C., Hunt, K., Ajani, J., McFadden, D., Nelson, S., Nesbitt, J., Putnam, JB Jr.,
          Vaporciyan, A.A., Walsh, G.L., Sinner, M., and Roth, J.A. The University of Texas M. D. Anderson Cancer
          Center, Houston Texas and University of California at Los Angeles, Los Angeles, California, Impact of Number
          of Involved Lymph Nodes on Long - Term Survival in Esophageal Cancer. Society of Surgical Oncology 51 st
          Annual Cancer Symposium, San Diego, California, 1998.
    16.   Ueno, N.T., Hung, M.C., Zhang, S., Xia, W., Willey, J.S., Warner, D.L., Payne, J.Y., Nandagiri, R., Aldridge, R.,
          De Jager, RL., Tucker, S., Putnam, JB Jr., Sneige, N., Katz, R.L., Spohn, W.H., Bast, R.C., Holmes, F.A.,
          Ibrahim, N.K., Theriault, R.L., Rahman, Z.U., Valero, V., Kudelka, A.P., Kavanagh, J.J., Freedman, R.S., Wolf,
          J.K., Gershenson, D.M., Bevers, M.W., Huang, L., Lopez - Berestein, G., and Hortobagyi, G.N. Phase I E1A
          gene therapy in patients with advanced breast and ovarian cancers. American Association for Cancer Research,
          New Orleans, LA, 1998.
    17.   Shin, D.M., Walsh, G.L., Putnam, JB Jr., Komaki, R., Cox, J.D., Roth, J.A., and Hong, W.K. Recent Advances
          in the Management of Malignant Thymoma. 41st Annual Clinical Conference, “New Frontiers in Research and
          Treatment of Aerodigestive Tract Cancers”, Houston, Texas, 1998.
    18.   Swisher, S.G., Roth, J.A., Neumanitis, J., Lawrence, D.D., Kemp, B.L., Carrasco, C.H., Connors, D.G., El -
          Naggar, A.K., Fossela, F.V., Glisson, B.S., Hong, W.K., Khuri, F.R., Kurie, J.M., Lee, J.J., Lee, J.S., Merritt, J.A.,
          Nesbitt, J.C., Nguyen, D., Pisters, K.M.W., Putnam, JB Jr., Schrump, D.S., Shin, D.M., Perez - Soler, R., and
                                                             - 21 -
Joe B. Putnam, Jr., M.D.                                                                     Rev: May 2010

    Abstracts (cont.):

          Walsh, G.L. Adenoviral mediated p53 gene transfer in patients with advanced non - small cell lung cancer
          (NSCLC). American Society of Clinical Oncology, Los Angeles, CA, 1998.
    19.   Nesbitt, J.C., Ajani, J.A., Komaki, R., Walsh, G.L., Putnam, JB Jr., Swisher, S.G., Pisters, P., Lynch, P.,
          Raijman, I., Pazdur, R., Delclos, M., and Martin, F. Preoperative taxol - based chemotherapy (CT) followed by
          chemoradiation therapy (CTRT) in patients (PTS) with potentially resectable esophageal carcinoma (EC).
          American Society of Clinical Oncology, Los Angeles, CA, 1998.
    20.   Putnam, JB Jr., Roth, J.A., Walsh, G.L., Swisher, S.G., Merriman, K.W., and DeFord, L.L. The University of
          Texas M. D. Anderson Cancer Center, Houston, Texas, USA, Early Cost comparison between Tube
          Thoracostomy vs. Chronic Indwelling Pleural Catheter (Pleurx) for Treatment of Malignant Pleural Effusion.
          Southern Thoracic Surgical Association, Orlando, Florida, 1998.
    21.   Gandhi, S., Gokaslan, Z., Komaki, R., Putnam, JB Jr., Roth, J.A., Smythe, W.R., Walsh, G.L., Willis, K.M.,
          Vaporciyan, A.A., and Swisher, S.G. An Aggressive Multidisciplinary Surgical Approach to Superior Sulcus
          Tumors with Vertebral Invasion can lead to Long - Term Survival. The Society of Thoracic Surgeons, San
          Antonio, Texas, 1998.
    22.   Swisher, S.G., Nemunaitis, J., Roth, J.A., Lawrence, D., Kemp, B., El - Naggar, A., Hong, W.K., Mack, M.,
          Weill, D., Merritt, J., Putnam, JB Jr., and Walsh, G.L. Outcome of Intralesional Adenoviral p53 Gene
          replacement with or without Cisplatin in Patients with Advanced Non - Small Cell Lung Cancer. Proceedings of
          the American Association of Thoracic Surgery, 1999.
    23.   Smythe, W.R., Consorti, E., Walsh, G.L., Putnam, JB Jr., Swisher, S.G., Vaporciyan, A.A., and Roth, J.A.
          Surgical Therapy for Metastatic Thyroid Carcinoma to the Mediastinum and Lung. Society of Thoracic Surgeons,
          Fort Lauderdale, Florida, 2000.
    24.   Walsh, G.W., Davis, B.M., Swisher, S.G., Vaporciyan, A.A., Smythe, W.R., Roth, J.A., and Putnam, JB Jr., A
          Single - Institution, Multidisciplinary Approach to Primary Sarcomas Involving the Chest Wall Requiring Full
          Thickness Resections, American Association for Thoracic Surgery, Toronto, Ontario, Canada, 2000.
    25.   Putnam, JB Jr., Benjamin, R.S., Rha, S.J., Tran, H.T., Walsh, G.L., Swisher, S.G., et al. Early results of isolated
          single lung perfusion for treatment of unresectable sarcomatous metastases. American Association for Thoracic
          Surgery 80th Annual Meeting (Toronto, Canada), April 30 – May 3, 2000.
    26.   Putnam, JB Jr., Thomsen, S.L., and Siegenthaler, M. Therapeutic Implications of Heat - Induced Lung Injury.
          SPIE‟s BiOS 2000 The International Symposium on Biomedical Optics, San Jose, California, 2000.
    27.   Siegenthaler, M., Pisters, K.M., Merriman, K.W., Swisher, S.G., Roth, J.A., Walsh, G.L., Vaporciyan, A.A.,
          Smythe, W.R., and Putnam, JB Jr.. Preoperative Chemotherapy for Lung Cancer Does Not Increase Surgical
          Morbidity. 36th Annual Meeting of The Society of Thoracic Surgeons, 2000.
    28.   Lewin, J.S., Hebert, T.M., DuBrow, R.A., and Putnam, JB Jr., Experience with the Chin Tuck Maneuver in Post
          - Esophagectomy Aspirators. Dysphagia Research Society 9 th Annual Scientific Meeting, Savannah, Georgia,
          2000.
    29.   Walsh, G.L., Bryan, M.D., Swisher, S.G., Vaporciyan, A.A., Smythe, W.R., Willis - Merriman, K., Roth, J.A.,
          and Putnam, JB Jr., A Single - Institutional, Multidisciplinary Approach to Primary Sarcomas Involving the
          Chest Wall requiring Full Thickness Resections. AATS 80th Annual Meeting, Toronto, Ontario, Canada, 2000.
    30.   Vaporciyan, A.A., Merriman, K.W., Ece, F., Roth, J.A., Smythe, W.R., Swisher, S.G., Walsh, G.L., and Putnam,
          JB Jr., Impact of Timing of Smoking Cessation on Pulmonary Morbidity after Pneumonectomy, Southern
          Thoracic Surgical Association, Marco Island, Florida, 2000.
    31.   Schnirer, I., Komaki, R., Yao, J., Swisher, S.G., Putnam, JB Jr., Pisters, P., Roth, J.A., Yan, M., Janjan, N.,
          Mansfield, P., Feig, B., and Ajani, J. A Study of Concurrent 5FU/Paclitaxel and Radiotherapy in Patients with
          Carcinoma of the Upper Gastrointestinal Tract. Immunobiol and Biologic Ther., 2000.
    32.   Swisher, S.G., Roth, J.A., Komaki, R., Hicks, M., Dreiling, L., Yver, A., Ahrar, K., Morello, F., Shelton, T.,
          Dolormente, M., Francisco, R., Vaporciyan, A.A., Smythe, W.R., Putnam, JB Jr., Steven, C., Kelly, J., Liao, Z.,
          Kemp, B., Hong, W.K., Munden, R., Ro, J., Morice, R., Huaringa, A., Mosheim, M., and Walsh, G.L. A Phase II
          Trial of Adenoviral Mediated P53 Gene Transfer (RPR.INGN 201) in Conjunction with Radiation therapy in
          Patients with Localized Non - Small Cell Lung Cancer (NSCLC), American Society of Clinical Oncology 19,
          461a - 461a, 2000.
    33.   Komaki, R., Roth, J.A., Putnam, JB Jr., Swisher, S., Vaporciyan, A., Lee, J.S., Fossella, F., Chasen, M., and
          Cox, J.D. Multidisciplinary approach for 143 patients with superior sulcus tumors treated at University of Texas
          M.D. Anderson Cancer Center. J ASTRO 12:110, 2000.
    34.   Mohiuddin, I.*, Sharma, C., Burnett, M., Putnam, JB Jr., Vaporciyan, A. Characterization of acute lung injury
          after isolated lung perfusion with doxorubicin, Am. College of Chest Phys., 118:1535, 2000.


                                                            - 22 -
Joe B. Putnam, Jr., M.D.                                                                      Rev: May 2010

    Abstracts (cont.)

    35. Swisher, S.G., Ajani, J.A., Komaki, R.R., Walsh, G.L., Nesbitt, J.C., Martin, F.D., Lahotie, S., Smythe, W.R.,
        Vaporciyan, A.A., Putnam, JB Jr., and Roth, J.A. Improved long - term survival in esophageal cancer following
        the novel strategy of induction chemotherapy prior to concurrent chemoradiation and surgery, Western Thoracic
        Surgical Association Meeting, San Diego, CA, 2001.
    36. Ajani, J., Komaki, r., Walsh, G.L., Putnam, JB Jr., Swisher, S.G., Lahoti, S., Ho, L., Faust, J., Roe, J., Smythe,
        W.R., Vaporciyan, A. a., Pisters, P., Kelly, J., Stevens, C., and Roth, J.A. CPT - 11 plus cisplatin as induction
        chemotherapy followed by chemoradiotherapy in resectable carcinoma of the esophagus and GE junction (EC -
        GEJC). Proc. Am. Soc. Clin. Oncol., 20 430a, 2001.
    37. Xiong, Q., Yao, J.C., Phan, A., Giacco, G., Hess, K., Roth, J. A., Putnam, JB Jr., Walsh, G.L., Swisher, S.G.,
        Mansfield, P.F., Pisters, P.W., Feig, B.W., and Ajani, J.A. Frequency of esophagogastric junction involvement
        among upper gastrointestinal cancers. Proc. Am. Soc. Clin. Oncol., 20, 430a, 2001.
    38. Swisher, S.G., Roth, J.A., Komaki, R., Hicks, M., Ro, J., Hong, W.K., Ahrar, K., Atkinson, N., Correa, A. M.,
        Dolormente, M., Dreiling, L., Fossella, F., Francisco, R., Glisson, B., Grammer, S., Herbst, R., Huaringa, A., Gu,
        J., Kelly, J., Kemp, B., Khuri, F.R., Kurie, J. M., Lee, J. J., Lee, J. S., Liao, Z., McDonnell, T. J., Merritt, J. A.,
        Morice, R., Morello, F., Mosheim, M., Munden, R., Papadimitrakopoulou, V., Pisters, K. M. W., Putnam, JB Jr.,
        Sarabia, A. J., Shelton, T., Stevens, C., Shin, D.M., Smythe, W. R., Vaporciyan, A., Walsh, G. L., Yin, M., and
        Yver, A. Induction of p53 regulated genes and tumor regression in lung cancer following intratumoral delivery of
        adenoviral p53 (RPR/INGN 201) and radiation therapy. Proc. Am. Soc. Clin. Oncol., 20, 257a, 2001.
    39. Putnam, JB Jr., Sarabia, A. J., Shelton, T., Stevens, C., Shin, D.M., Smythe, W. R., Vaporciyan, A., Walsh, G.
        L., Yin, M., and Yver, A. Induction of p53 regulated genes and tumor regression in lung cancer following Intra -
        tumoral delivery of adenoviral p53 (RPR/INGN 201) and radiation therapy. Proc. Am. Soc. Clin. Oncol., 20,
        257a, 2001.
    40. Reinmuth, N., Ahmad. S. A., Curley, S. A., Vauthey, J. N., Putnam, JB Jr., and Ellis, L. M. Resection of hepatic
        and pulmonary metastases in patients with colorectal carcinoma. Proc. Am. Soc. Clin. Oncol., 20, 105b, 2001.
        Pisters, K., Ginsberg, R., Giroux, D., Kris, M., Putnam, JB Jr., Roberts, J. R., Johnson, D. H., Crowley, J., and
        Bunn, P. Phase II bimodality lung oncology team (BLOT) trial of induction paclitaxel/carboplatin (PC) in early
        stage non - small cell lung cancer (NSCLC): effect of number of induction cycles, sites of relapse and survival.
        Proc. Am. Soc. Clin. Oncol., 20, 323a, 2001.
    41. Kim, E.S., Putnam, JB Jr., Komaki, R., Walsh, G.L., Ro, J. Y., Shin, H.J., Lee, J.J., Swisher, S. G., Fossela, F.
        V., Khuri, F. R., Hong, W. K., and Shin, D. M. A phase II study of a multidisciplinary approach with induction
        chemotherapy (IC), followed by surgical resection (SR), radiation therapy (RT) and consolidation chemotherapy
        (CC) for unresectable malignant thymomas: final report. Proc. Am. Soc. Clin. Oncol., 20, 310a, 2001.
    42. Swisher, S., Wynn, P., Mosheim, M., Putnam, JB Jr., Komaki, R., Ajani, J., Smythe, W.R., Vaporciyan, A.,
        Roth, J., and Walsh, G. Is surgical salvage indicated for recurrent esophageal tumors following definitive
        chemoradiation? Proc. Am. Soc. Clin. Oncol., 146:46, 2001.
    43. Yang, S. C., Whyte, R. I., Askin, F., Thomsen, S. L., Tamboli, P, Berry, G., Roig, C., and Putnam JB, Jr.,
        Radiofrequency Ablation of Primary and Metastatic Lung Tumors: Analysis of an Ablate and Resection Study.
        American Association for Thoracic Surgery 82nd Annual Meeting, 210. 2002.
    44. Putnam, JB Jr., Roberson, S. L., Lewin, J. S., Correa, A. M., Swisher, S. G., Walsh, G. L., Rice, D. C.,
        Vaporciyan, A. A., Roth, J. A., and Smythe, W. R. Risk Analysis For Pneumonia Following Esophagectomy. The
        Society of Thoracic Surgeons 39th Annual Meeting 39, 258 - 259. 2003.
    45. Rice, D. C., Kim, H. W., Smythe, W. R., Swisher, S. G., Vaporciyan, A. A., Putnam, JB Jr., Walsh, G. L.,
        Lippman, S. M., Roth, J. A., Sabichi, A., and Lee, J. J. The Risk Of Second Primary Lung Cancer After Resection
        Of Stage I Non Small Cell Lung Cancer. The Society of Thoracic Surgeons 39th Annual Meeting 39, 108. 2003.
    46. Meyers, B.F., Downey, R.J., Kenan, R.J., Siegel, B.A., Cerfolio, R.J., Landreneau, R.J., Putnam, JB Jr., et al.
        The utility of positron emission tomography in staging of patients with potentially operable carcinoma of the
        thoracic esophagus. American Association for Thoracic Surgery Annual Meeting, Philadelphia, PA, 2006.
    47. Toloza, E.M., Meyers, B.F., Mackie - McCall, L., Reed, C.E., Putnam, JB Jr. Prevalence of mediastinal
        metastases and sensitivity of mediastinoscopy in potentially operable non - small cell lung cancer screened by
        computerized tomography and positron emission tomography. American Association for Thoracic Surgery
        Annual Meeting, Abstract # 19; Philadelphia, PA, 2006.
    48. Allen, M.S., Darling, G.E., Decker, P.A., Putnam, JB Jr., Malthaner, R.A., Inculet, R.I., Jones, D.R., McKenna,
        R.J., Landreneau, R.J. Number of lymph nodes harvested from a mediastinal lymphadenectomy; results of the
        randomized, prospective ACOSOG Z0030 trial. ASCO Annual Meeting, Chicago, IL, July 2007.
    49. Kozower, B.D., Meyers, B.F., Reed, C.E., Jones, D.R., Decker, P.A., Putnam, JB Jr. Does FDG - PET Prevent
        Nontherapeutic Thoracotomies for Clinical Stage IA Lung Cancer? A subset Analysis of the ACOSOG Z0050
        Trial. (Submitted, Southern Thoracic Surgery Association, May, 2007.
                                                            - 23 -
Joe B. Putnam, Jr., M.D.                                                                   Rev: May 2010

    Abstracts (cont.)

    50. Deppen, SA, Andrade GM, Lambright ES, Nesbitt JC, Massion PP, Putnam JBJr, Grogan EL. FDG-PET does
        not accurately diagnose early stage lung cancer in an area of endemic histoplasmosis and other granulomatous
        disease. Cancer Epidemiology, Biostatistics and Bioinformatics Retreat – Vanderbilt Ingram Cancer Center,
        Nashville, TN; December 4, 2009.
    51. Fibla JJ, Putnam JBJr, Ota D. Validation of the lung cancer staging system revisions using a large prospective
        clinical trial database (ACOSOG Z0030). Accepted for presentation, American Society of Clinical Oncology,
        2010.
    52. Fernando HC, Landreneau RJ, Mandrekar S, Hillman S, Nichols FC, Meyers B, Dipetrillo T, Heron DE, Putnam,
        JB Jr. The Impact of Adjuvant Brachytherapy with Sublobar Resection on Pulmonary Function and Dyspnea;
        Preliminary Results from ACOSOG Z4032 Trial. American Association for Thoracic Surgery Annual Meeting,
        San Diego, CA, May, 2010.
    53. Darling GE, Allen MS, Decker P, Ballman KV, Landreneau RJ, McKenna RJ, Jones DR, Inculet RI, Rusch VW,
        Putnam, JBJr. 1. Randomized Trial of Mediastinal Lymph Node Sampling versus Complete Lymphadenectomy
        during Pulmonary Resection in Patients with N0 or N1 (Less than Hilar) Non-small Cell Carcinoma: Results of
        the ACOSOG Z0030 Trial. American Association for Thoracic Surgery Annual Meeting, San Diego, CA, May,
        2010.

    Book Chapters

    1.    Putnam, JB Jr., and Roth, J.A. Resection of pulmonary metastases. In: J.E. Niederhuber (ed.), Current Therapy
          in Oncology, pp. 197 - 201, Philadelphia, B.C. Decker, Inc., 1992.
    2.    Putnam, JB Jr., Ryan, M.B., Walsh, G.L., and Roth, J.A. Malignant disease of the lung. In: E.M. Copeland, III,
          and B.A. Levine (eds.), Current Practices of Surgery, pp. 1 - 44, New York, Churchill Livingstone, Inc., 1993.
    3.    Putnam, JB Jr., and Roth, J.A. Resection of sarcomatous pulmonary metastases. soft tissue Sarcomas of the
          limbs, In: W. Lawrence, Jr. (ed.), Surgical Oncology Clinics of North America, pp. 673 - 691, Philadelphia, W.B.
          Saunders Co., 1993.
    4.    Putnam, JB Jr., and Roth, J.A. Neoplastic Diseases of the Esophagus. In: R.H. Bell, L.F. Rikkers, and M.W.
          Mulholland (eds.), Digestive Tract Surgery: A Text and Atlas, pp. 43 - 75, Philadelphia: J.B., Lippincott, 1993.
    5.    Roth, J.A., and Putnam, JB Jr., Cancer of the esophagus. In: V.T. DeVita, Jr., S. Hellman, and S.A. Rosenberg
          (eds.), Cancer: Principles & Practice of Oncology, pp. 776 - 817, Philadelphia: J.B., Lippincott Co., 1993.
    6.    Putnam, JB Jr., and Roth, J.A. Surgical resection of pulmonary metastases. In: R.J. McKenna, and G.P. Murphy
          (eds.), Cancer Surgery, Philadelphia, pp. 337 - 350, J.B., Lippincott Co., 1994.
    7.    Putnam, JB Jr., Esophagectomy for carcinoma of the esophagus. In: M. Roh (ed.), Atlas of Advanced
          Oncologic Surgery, pp. 704 - 711, New York, Gower Med Publishing, 1994.
    8.    Putnam, JB Jr., and Roth, J.A. Secondary tumors in the lung. In: T. W. Shields (ed.), General Thoracic Surgery,
          pp. 1334 - 1352, Philadelphia, Lea and Feibiger Publishers, 1994.
    9.    Roth, J.A., and Putnam, JB Jr., New insights into selecting patients likely to benefit from resection of
          pulmonary metastases. In: G. Motta and L.P. Grafica (ed.), Lung Cancer Frontiers in Science and Treatment, pp.
          473 - 482, Genoa, Italy, 1994.
    10.   Roth, J.A., and Putnam, JB Jr.. Surgery for carcinoma of the esophagus. In: J.R. Ruckdeschel, and T.
          Weisenberger (eds.), Thoracic Oncology, pp. 397 - 432, Philadelphia, W.B. Saunders, 1995.
    11.   Putnam, JB Jr., and Roth, J.A. Neoplasms of the esophagus. In: R.H. Bell, L.F. Rikkers, and M.W. Mulholland
          (eds.), Digestive Tract Surgery: A Text & Atlas, pp. 43 - 76, Philadelphia, J. B. Lippincott Company, 1995.
    12.   Nesbitt, J.C., Putnam, JB Jr., Walsh, G.L., Ryan, M.B., and Roth, J.A. Malignant diseases of the lung. In: B.A.
          Levine, E.M. Copeland III, R.F. Howard, H.J. Sugerman, and A.L. Warshaw (eds.), Current Practice of Surgery,
          pp. 1 - 54, New York, Churchill Livingstone Inc., 1995.
    13.   Lanza, L.A., and Putnam, JB Jr., Resection of pulmonary metastases. In: J.A. Roth, J.R. Ruckdeschel, and T.H.
          Weisenberger (eds.), Thoracic Oncology 2nd Edition, pp. 569 - 589, Philadelphia, W.B. Saunders, 1996.
    14.   Putnam, JB Jr., Exploratory Thoracoscopy. In: B. MacFadyen, and J. Ponsky (eds.), Operative Laparoscopy and
          Thoracoscopy, pp. 829 - 848, New York, Raven Press, 1996.
    15.   Roth, J.A., Putnam, JB Jr., Rich, T., and Forestiere, A. Cancer of the esophagus. In: V.T. DeVita, S. Hellman,
          and S.A. Rosenberg (eds.), CANCER: Principles and Practices of Oncology, pp. 980 - 1010, Philadelphia, J.B.,
          Lippincott - Raven, 1996.
    16.   Roth, J.A., and Putnam, JB Jr., Pulmonary resection for metastatic disease. In: H. Silberman, and A.W.
          Silberman (eds.), Difficult Problems in Surgical Oncology, New York, Chapman and Hill, 1996.
    17.   Roth, J.A., Beech, D.J., Putnam, JB Jr., and Pollock, R.E., Patel, S.R., Fidler, I.J., and Benjamin, R.S.
          Treatment of the patient with lung metastases, Curr. Probl. Surg., 33:881 - 952, 1996.
                                                           - 24 -
Joe B. Putnam, Jr., M.D.                                                                 Rev: May 2010


    Book Chapters (cont.)

    18. Putnam, JB Jr., The mediastinum: overview and diagnostic approach. In: J. Fishman, M.A. Grippi, L.R. Kaiser,
        and R.M. Senior (eds.), Pulmonary Diseases and Disorders, pp. 1469 - 1484, Ontario, Canada, B.C. Decker Inc.
        Publisher, 1997.
    19. Putnam, JB Jr., Morris, P.*, and Roth, J.A. Esophageal Carcinoma. In: A.W. Silberman, and H. Silberman
        (eds.), Difficult Problems in Surgical Oncology, New York, Chapman & Hill, 1997.
    20. Putnam, JB Jr., Surgery for pulmonary metastases. In: Advanced Therapy in Thoracic Surgery. K.L. Franco,
        and Putnam, JB Jr. (eds.), Ontario, Canada, B.C. Decker Inc., Publisher, 1997.
    21. Swisher, S.G., and Roth, J.A. Role of gene therapy in lung cancer. In: L.L. Franco, and Putnam, JB Jr. (eds.),
        Advanced Therapy in Thoracic Surgery, pp. 139 - 145, Ontario, Canada, B.C. Decker, Inc., 1998.
    22. Putnam, JB Jr., Pulmonary resection for metastatic diseases. In: H. Silberman, and A.W. Silberman (eds.),
        Problems in Surgical Oncology, New York, Chapman & Hill, 1999.
    23. Putnam, JB Jr., Secondary tumors of the lungs. In: T.W. Shields (Hon.), J. LoCicero, III, and R.B. Ponn (eds.),
        General Thoracic Surgery, Fifth Edition, pp. 1555 - 1576 Philadelphia, Pennsylvania, Lippincott Williams &
        Wilkins, 1999.
    24. Putnam, JB Jr.. Lung (Including Pulmonary Embolism and Thoracic Outlet Syndrome). In: Sabiston Textbook
        of Surgery: The biological basis of modern surgical practice, 16 th Edition. C.M. Townsend, Jr., R.D. Beauchamp,
        B.M. Evers, and K.L. Mattox (eds.), pp. 1205 - 1242, Philadelphia, Pennsylvania, W.B. Saunders Company, 2000.
    25. Putnam, JB Jr., Metastatic cancer to the lung. In: Cancer: Principles and Practice of Oncology, Sixth Edition.
        V.T. DeVita, Jr., S. Hellman, and S.A. Rosenberg (eds.), pp. 2670 - 2686, Philadelphia, Pennsylvania, Lippincott
        Williams & Wilkins, 2001.
    26. Putnam, JB Jr., and Roth, J.A. Pulmonary metastases. Surgical Oncology. H. Silberman and A.W. Silberman
        (eds.), pp. 742 - 764, London, Arnold Publishers, 2002.
    27. Putnam, JB Jr., Post - resection Follow - Up for Non - Small Cell Lung Cancer. Thoracic Surgery 2nd Edition.
        F.G. Pearson, J.D. Cooper, J. Deslauriers, R.J. Ginsberg, C.A. Hiebert, G.A. Patterson, and H.C. Urschel, Jr.
        (eds.), pp. 918 - 924, Philadelphia, Pennsylvania, Churchill Livingstone, 2002.
    28. Putnam, JB Jr., Implementation of multidisciplinary care in the treatment of patients with lung cancer. M. D.
        Anderson Cancer Care Series: Lung Cancer, F.V. Fossella, and R. Komaki (eds.), pp. 1 - 24, New York, Springer
        - Verlag, 2003.
    29. Putnam, JB Jr., Palliative care in patients with lung cancer. M. D. Anderson Cancer Care Series: Lung Cancer,
        F.V. Fossella, and R. Komaki (eds.), pp. 220 - 240, New York, Springer - Verlag, 2003.
    30. Ajani, J., Burak, W. E., D'Amico, T. A., Douglas, H. O., Eisenberg, B. L., Fuchs, C., Goldberg, M., Hayman, J.
        A., Javie, M., Karl, R. C., Koczywas, M., Kurtz, R. C., Locker, G. Y., Meropol, N. J., Minsky, B., Orringer, M.
        B., Posey, J. A., Putnam, JB Jr., Roth, J. A., Sasson, A. R, and Wood, D. E. Esophageal Cancer. Winn, R. J.
        NCCN Practice Guidelines in Oncology (http://www.nccn.org) V.1.2003, 1 - 22. 2003. Rockledge, PA, National
        Comprehensive Cancer Network.
    31. Putnam, JB Jr., Lung (including pulmonary embolism and thoracic outlet syndrome). In Sabiston Textbook of
        Surgery (17th edition), pp 1763 – 1812. Townsend CM Jr., Beauchamp RD, Evers, BM, Mattox, KL (Eds.).
        Elsevier Saunders, Philadelphia, 2004.
    32. Antevil JL*, Putnam JB Jr., Evaluation of the Patient with a diagnosis of non - small cell lung carcinoma. In
        New Treatment Paradigms in Non - Small - Cell Lung Cancer. Sandler AB (Ed), pp 95 – 120, CMP Medica, New
        York, 2006.
    33. Karamichalis JM*, Putnam, JB Jr., Lambright ES. Cardiovascular Complications after Lung Surgery. Thorac
        Surg Clin 16: 253 - 260, 2006.
    34. Putnam, JB Jr., Lung and Bronchus. In Textbook of Surgical Oncology, pp 77 – 92. Poston GJ, Beauchamp RD,
        Ruers R (eds.); Informa Healthcare, London, 2007.
    35. Smyth WR, Reznik SI, Putnam, JB Jr., Lung (including pulmonary embolism and thoracic outlet syndrome). In
        Sabiston Textbook of Surgery (18th edition), pp 1698 – 1748. Townsend CM Jr., Beauchamp RD, Evers BM,
        Mattox KL (Eds.). Elsevier Saunders, Philadelphia, 2008.
    36. Putnam, JB Jr., Postresection Follow - up for Non - Small Cell Lung Cancer. In Pearson‟s Thoracic and
        Esophageal Surgery (3rd edition), pp 790 - 795. Patterson GA, Cooper JD, Deslauriers J, Lerut AEMR, Luketich
        JD, Rice TW. Churchill Livingstone Elsevier, Philadelphia, 2008.

Books (edited and written)

    1.   Franco, K.L., and Putnam, JB Jr., (eds.), Advanced Therapy in Thoracic Surgery, Hamilton, Ontario, Canada,
         B.C. Decker, Inc., 1998.
                                                         - 25 -
Joe B. Putnam, Jr., M.D.                                                                 Rev: May 2010

    Books (edited and written) cont.

    2.   Toledano A.Y., Olak, J., Statistical Techniques and Analysis in Thoracic Surgery. Franco, K.L., Putnam, JB Jr.,
         editors, 1st ed. Hamilton, Ontario, Canada: B.C. Decker, p. 146, 1998.
    3.   Nesbitt, J.C. Walsh, G.L. Surgical Management of Esophageal Perforation; Advanced Therapy in Thoracic
         Surgery, Franco, K.L., Putnam, JB Jr., editors. Hamilton, Ontario, Canada: B. C. Decker, pp. 500 - 11, 2001.
    4.   Nesbitt, J.C., and Wind, G.G. (Eds.). Thoracic Surgical Oncology: Exposures and Techniques. Lippincott
         Williams and Wilkins, New York, 2003. Consulting Editors: Deslauriers, J., Faber, L.P., Ginsberg, R.J., Moores,
         D.W.O., Orringer, M.B., Paterson, G. A., Putnam, JB Jr., Rice, T.W., Rusch, V.W., Stewart, J.R., Walsh, and
         G.L.
    5.   Fossella, F.V., Komaki, R., and Putnam, JB Jr., Lung Cancer: M.D. Anderson Cancer Care Series. 2003.
         Series Editors Buzdar, A.U., and Freedman, R.S.
    6.   Franco, K.L. and Putnam, JB Jr., Advanced Therapy in Thoracic Surgery 2/e. May 2005. BC Decker Publishers.
    7.   Putnam, JB Jr. and Franco KL., Advanced Therapy in Thoracic Surgery 3/e in preparation. BC Decker
         Publishers

Letters to the Editor

    1.   Baciewicz, F.N., Putnam, JB Jr., Naunheim, KS, and Kaiser, LR. Isolated lung perfusion with melphalan for the
         treatment of metastatic pulmonary sarcoma - Discussion. J Thor Cardiovasc Surg, 112:1547 - 1548, 1996.
    2.   Mathisen, D.J., Landreneau, R., Putnam, JB Jr., and Trastek, V.F. Acute and chronic morbidity differences
         between muscle - sparing and standard lateral thoracotomies - Discussion. J Thor Cardiovasc Surg, 112:1350 -
         1351, 1996.
    3.   Miller, J.I., Wright, and Putnam, JB Jr., Post - pneumonectomy bronchopleural fistula after sutured bronchial
         closure - incidence, risk factors, and management - Discussion. J Thor Cardiovasc Surg, 112:1371, 1996.
    4.   Swisher, S.G., and Putnam, JB Jr., Influence of lymph node dissection on survival in esophageal cancer. J Surg
         Oncol, 69:117 - 8, 1998.
    5.   Putnam, JB Jr., Lung Cancer. Semin. Surg. Oncol., 18:89 - 90, 2000.

Manuals, Teaching Aids, Other Publications

    1.  Putnam, JB Jr., and Roth, J.A. Resection of pulmonary metastases from patients with osteogenic and soft tissue
        sarcomas. Medical Portfolio for Cardiovascular and Thoracic Surgeons, Vol. A, No. 2, 1983.
    2. Putnam, JB Jr., Sweeney, M.S., Papadapolous, N.E.J., Melissinos, E.M., and Williams, J.P. En bloc resection of
        a mediastinal malignant fibrous histiocytoma with aortic arch reconstruction. Am Col Surg, Symposium on
        Spectacular Problems in Surgery, San Francisco, CA, 1990.
    3. Putnam, JB Jr., Sweeney, M.S., Papadapolous, N.E.J., Melissinos, E.M., and Williams, J.P. En bloc resection of
        a mediastinal malignant fibrous histiocytoma with aortic arch reconstruction. Surgical Motion Pictures, Soc
        Thorac Surg, Orlando, FL, 1992.
    4. Putnam, JB Jr., and Roth, J.A. Resection of pulmonary metastases from patients with osteogenic and soft tissue
        sarcomas. Medical Portfolio for Cardiovascular and Thoracic Surgeons, Vol. A, No 2, 1983.
    5. Putnam, JB Jr., Soysal, O., Roth, J.A., Walsh, G.L., Nesbitt, J.C., and Schrump, D.S. Results of esophagectomy
        for severe dysplasia in Barrett‟s esophagus. International Society for Diseases of the Esophagus (ISDE) Video -
        Library, Milan, Italy, 1996.
    6. Putnam, JB Jr., “Managing Cancer”, video - based educational program outline for the public on breast, cervical,
        colorectal and lung cancer; FYI/Now, in conjunction with Society of Surgical Oncology, 2006.
    7. Putnam, JB Jr., Walsh, G.L., Nesbitt, J.C., McMurtrey, M.J., Roth, J.A., Suell, A., Schrump, D.S., Ohnmacht,
        G.A. and Willis, K.M. The technique of esophagectomy does not influence survival after resection of esophageal
        carcinoma. 6th World Congress of the International Society of Diseases of the Esophagus (ISDE), Video -
        Library, Milan, Italy, 1996.
    8. Putnam, JB Jr., Prospective Database for Thoracic Surgical Oncology, 1998.
    9. Putnam, JB Jr., Walsh, GL, Swisher SG, Roth JA, Suell DM, Vaporciyan AA, Smythe WR, Meerriman KW,
        DeFord LL. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter.
        Center for Reviews and Dissemination, National Health Service, Economic Evaluation Database. 2004.
        Document number 289876.
    10. Dellinger, EP, Gordon, SM, Blackshear, RH, Putnam, JB Jr., Crosby CT, Foor, JS, Botte, MJ, Culligan P.
        Special Report: Surgical - Associated Infection in Today‟s Operating Room. Medi - Flex. McMahan Publishing
        Group, July, 2006.

                                                         - 26 -
Joe B. Putnam, Jr., M.D.                                                                     Rev: May 2010

Manuals, Teaching Aids, Other Publications (cont.)

     11. Altorki N, Bunn PA Jr, Langer CUJ, Ota D, Putnam JB Jr. Tailoring the Treatment of Non - Small Cell Lung
         Cancer (NSCLC): From the surgeon to the Oncologist. Medical Education Resources, Inc., Curry Rockefeller
         Group/Oncology. (CME program content/education material development), 2007.

         Other

         National Comprehensive Cancer Network, NCCN Practice Guidelines for Esophageal Cancer, 2000.

EDITORIAL AND REVIEW ACTIVITIES:

     Editorial Board

         Annals of Surgical Oncology, Thoracic Oncology, Associate Section Editor
         Journal of the American College of Surgeons
         Annals of Thoracic Surgery, ad hoc Reviewer

     Journal Reviewer
         Annals of Thoracic Surgery
         Annals of Surgical Oncology
         Associazione Italiana per la Ricerca sul Cancro (AIRC)
         Cancer
         Cancer Immunology Immunotherapy
         Cancer Bulletin
         Chest
         Circulation
         Clinical Cancer Research
         Head and Neck
         International Journal of Radiation Oncology
         Journal of the American College of Surgeons
         Journal of Clinical Oncology
         Journal of Surgical Oncology
         Journal of Surgical Research
         Journal Thoracic & Cardiovascular Surgery
         Military Medicine
         Surgery
         Surgical Laparoscopy Endoscopy and Percutaneous Techniques
         Turkish Journal of Thoracic and Cardiovascular Surgery

         Other

         Bayer Fellowship Selection Committee – 2007

         STUDY SECTION

         Member, F - 10 Study Section (diverse pre - , post - and senior post - doctoral applications, including those from
         respiratory, cardiovascular, nephrology, gastroenterology, bone biology, bioengineering, genetics, signaling, etc.)
         (2006)

Presentations at National or International Conferences

1.     Walter Reed Army Medical Center - Thoracic Rounds, Diagnosis and Surgical Management of Gastroesophageal
       Reflux and its Complications, 9/89.
1.     National Naval Medical Center, General Surgery Grand Rounds, Gastroesophageal Reflux, Bethesda, MD, 9/98.
2.     General Surgery Conference - Results of Pulmonary Surgery for Metastatic Sarcomas, 2/90.
3.     Department of General Surgery Grand Rounds - Pulmonary Resection for Metastases, 2/90.
4.     Hillcrest Baptist Medical Center Cancer Seminar, Limits of Surgical Resection for Primary Carcinoma of the Lung,
       4/90.
                                                           - 27 -
Joe B. Putnam, Jr., M.D.                                                                Rev: May 2010

      Presentations at National or International Conferences (cont.)

5.    The University of Iowa Surgery Grand Rounds, The Limits of Surgical Resection for Carcinoma of the Lung. 6/90.
6.    United States Naval Hospital Family Practice Grand Rounds, The Diagnosis and Management of Gastroesophageal
      Reflux, Twenty - Nine Palms, CA, 7/90.
7.    Department of Pediatrics Grand Rounds - Prognostic Indicators for Survival Following Resection of Pulmonary
      Metastases, 7/90.
8.    University of Tennessee at Memphis, Surgical Grand Rounds, Management of Pulmonary Metastases, 9/91.
9.    Association of Military Surgeons of the United States, Back - fill Experiences During Operation Desert Storm, San
      Antonio, TX, 11/91.
10.   The Society of Surgical Oncology Laparoscopic/Thoracoscopic Symposium, 46 th Annual Meeting, Thoracoscopic
      Resection of Pulmonary Tumors, Los Angeles, CA, 3/93.
11.   North Florida Hematology and Oncology Associates, St. Vincent‟s Medical Center Cancer Education Seminary,
      Cancer of the Esophagus, Jacksonville, FL, 5/93.
12.   Congress on Laparoscopy, Thoracoscopy, and Pelvioscopy, Video - assisted Thoracoscopy Istanbul, Turkey, 11/93.
13.   Congress on Laparoscopy, Thoracoscopy, and Pelvioscopy, Surgical Management of Esophageal Cancer, Istanbul,
      Turkey, 11/93.
14.   Bethesda Memorial Center, Annual Cancer Conference of The Center for Radiation Oncology, Surgical
      Management of Esophageal Cancer, West Palm Beach, FL, 11/93.
15.   Baptist Hospital of Southeast Texas Cancer Symposium, Video - assisted Thoracic Surgery, Beaumont, TX, 11/93.
16.   Baptist Hospital of Southeast Texas Cancer Symposium, Current Management of Esophageal Carcinoma,
      Beaumont, TX, 11/93.
17.   Society of Surgical Oncology 47th Annual Cancer, Symposium Surgery for Metastatic Disease - Resection of
      Pulmonary Metastases, 3/94.
18.   81st Annual Meeting of the Texas Radiologic Society, Carcinoma of the Esophagus, Austin, TX, 4/94.
19.   4th European Congress of Video Surgery, Application of V.A.T.S. Techniques in Thoracic Oncology, Istanbul,
      Turkey, 6/94.
20.   4th European Congress of Video Surgery, Thoracic Resection of Pulmonary Metastases, Istanbul, Turkey, 6/94.
21.    4th European Congress of Video Surgery, Thoracoscopy in the Staging and Treatment of Esophageal Carcinoma:
      Comment and Controversies, Istanbul, Turkey, 6/94.
22.   4th European Congress of Video Surgery, Risks and Complications in Video Surgery, Istanbul, Turkey, 6/94.
23.   3rd United States/Japan Clinical Trial Summit, Southwest Oncology Group, Treatment of Pulmonary Metastases,
      Seattle, WA, 8/94.
24.   Balboa Alumni of General Surgery Conference, Naval Medical Center. The Surgical Management of Esophageal
      Carcinoma: University of Texas M.D. Anderson Cancer Center Experience, San Diego, CA, 10/94.
25.   St. Thomas Regional Hospital, Perioperative Chemotherapy and Surgery in Stage III, Non - small Cell Lung Cancer,
      Norman, OK, 10/94.
26.   Current Management of Pulmonary Disease: Pleural Disorders Symposium Management of Malignant Pleural
      Effusion, St. Thomas Medical Center at Vanderbilt, Health Education Services, Laurence A. Grossman Medical
      Learning Center, Nashville, TN, 10/94.
27.   Bethesda Memorial Hospital 9 th Annual Clinical Cancer Conference, Current Trends in the Treatment of Carcinoma
      of the Lung, Surgical Management of Carcinoma of the Lung, Boynton Beach, FL, 11/94.
28.   Our Lady of the Lake Regional Medical Center, Management Update in Resectable Non - small Cell Lung Cancer,
      Baton Rouge, LA, 11/94.
29.   Bay Area Tumor Institute, Lung Conference, Current Therapies in the Treatment of Non - small Cell Lung Cancer,
      Oakland, CA, 2/95.
30.   Baptist Hospital Cancer Conference, Pensacola, FL., 2/95.
31.   General Thoracic Surgical Club 1995 Meeting, Resection of Pulmonary Metastases, South Seas Plantation Resort &
      Yacht Harbor, Captiva Island, FL, 3/95.
32.   St. John‟s Hospital, Oncology Symposium, Combined Modality Treatment of Non - small Cell Lung Cancer,
      Detroit, MI, 9/95.
33.   International Workshop of Lung Metastases, National Heart and Lung Institute, Role of VATS, London, England,
      10/95.
34.   International Workshop of Lung Metastases, Soft Tissue Sarcomas, National Heart and Lung Institute, London,
      England, 10/95.
35.   International Workshop of Lung Metastases, VATS, Panel Discussion, National Heart and Lung Institute, London,
      England, 10/95.
36.   Invited Speaker, Argentine Congress of Pneumology, Lung Cancer and VATS, Buenos Aires, Argentina, 10/95.

                                                        - 28 -
Joe B. Putnam, Jr., M.D.                                                               Rev: May 2010

      Presentations at National or International Conferences (cont.)

37.   Invited Speaker, Argentine Congress of Pneumology, Present Indications and Future Projections of VATS, Buenos
      Aires, Argentina, 10/95.
38.   Invited Speaker, Argentine Congress of Pneumology, VATS in Lung Cancer, Buenos Aires, Argentina, 10/95.
39.   International Society of Diseases of the Esophagus, Results of Esophagectomy for Severe Dysplasia in Barrett‟s
      Esophagus, Milan, Italy, 1995.
40.   International Society Diseases of The Esophagus, The Technique of Esophagectomy Does Not Influence Survival
      After Resection of Esophageal Carcinoma, Milan, Italy, 1995.
41.   Society of Thoracic Surgeons 32nd Annual Meeting, Resecting the Unresectable Thoracic Neoplasm, Orlando, FL,
      1/96.
42.   Wayne State University, Harper Hospital Oncology Grand Rounds, The Role of Surgery in the Management of
      Esophageal Carcinoma, Detroit, MI, 3/96.
43.   Wayne State University, Harper Hospital Lung Cancer Academic Conference, Neoadjuvant Chemotherapy Plus
      Surgery in the Treatment of Potentially Resectable Non - small Cell Lung Cancer, Detroit, MI, 3/96.
44.   IASLC Workshop, Limits of a Surgical Resection for Stage III Non - small Cell Lung Cancer, Brussels, Belgium,
      6/96.
45.   Harvard Medical School, Minimally Invasive Thoracic Surgery Interest Group International Symposium, Role of
      Minimally Invasive Surgery for Sub - lobar Pulmonary Resection of Peripheral Lung Cancer, Boston, MA, 9/96.
46.   Henry Ford Hospital Oncology Grand Rounds, Multimodality Treatment of Advanced Stage Lung Cancer: Surgery
      and Neoadjuvant Chemotherapy, Detroit, MI, 9/96.
47.   East Texas Lung Symposium, Neoadjuvant Therapy of Lung Cancer, Tyler, TX, 9/96.
48.   Memorial Regional Cancer Center, 12th Annual Symposium, Perspectives in Cancer, Diagnosis and Treatment,
      Modesto, CA, 9/96.
49.   Invited Discussant for Burt, M. and Gold, J. American College of Surgeons, Pulmonary Metastatectomy with
      Removal of Tumor Invading the Left Atrium: Sequential Approach, Thoracic Surgery Cline Clinics, San Francisco,
      CA, 10/96.
50.   The Royal Academy of Surgery and Medicine of Galacia, Video - assisted Thoracic Surgery: University of Texas
      M.D. Anderson Cancer Center Experience, LaCoruna, Spain, 10/96.
51.   Metástasis Pulmonares. III Reunión del Area de Oncologia de la Sociedad Espanola de Neumologia y Cirugia
      Torácica (SEPAR), Surgical Management of Pulmonary Metastases, LaCoruna, Spain, 10/96.
52.   John Alexander Society Meeting, Changing Roles in Thoracic Surgery, Ann Arbor, MI, 11/96.
53.   Caraway Cancer Center Cancer Symposium, The Surgical Treatment of Non - small Cell Lung Cancer During the
      Multimodality of Treatment of Non - small Cell Lung Cancer, Birmingham, AL, 12/96.
54.   2nd Andorran Congress on Lung Cancer, Neoadjuvant Chemotherapy in Non - small Cell Lung Cancer, Andorra,
      Spain, 2/97.
55.   Society of Thoracic Surgery Meeting, U - 10 Steering, MDACC ID91 - 025 - Phase III Double - blind Randomized
      Trial of 13 - cis Retinoic Acid to Prevent Second Primary Tumors in Stage I Non - small Cell Lung Cancer, San
      Diego, CA, 2/97
56.   Neurosciences/Oncology Symposium, Into the 21st Century: The Treatment of Advanced Stage Lung Cancer:
      Surgery/Chemotherapy/Gene Therapy, California Cancer Center, Monterey, CA, 3/97.
57.   New Mexico Society Clinical Society, Multimodality Treatment of Small - cell Lung Cancer, Albuquerque, NM,
      4/97.
58.   American Association for Thoracic Surgery, Surgery for Pulmonary Metastases, Washington DC, 5/97.
59.   American Association Thoracic Surgeons General Thoracic Surgery Symposium, Surgery for Metastatic Disease to
      the Lung, Washington DC, 5/97.
60.   Chest South Africa 1997 Conference, Neoadjuvant Chemotherapy and Surgery in the Treatment of Lung Cancer,
      Windhoek Namibia, South Africa, 9/97.
61.   Chest South Africa 1997 Conference, The Surgical Management of Esophageal Carcinoma, Windhoek Namibia,
      South Africa, 9/97.
62.   Chest South Africa 1997 Conference, Pulmonary Metastases: A Multidisciplinary Approach, Windhoek Namibia,
      South Africa, 9/97.
63.   Pulmonology Society Congress, Current Management of Advanced Stage Lung Cancer Windhoek Namibia, South
      Africa, 9/97.
64.   „8th World Conference on Lung Cancer. The Role of Thoracoscopy in the Diagnosis and Staging of Lung Cancer,
      Dublin, Ireland, 10/97.
65.   1st International Symposium in Current Concepts in Lung Cancer and Future Considerations for the XXI Century,
      Surgical Treatment of Advanced Lung Carcinoma: Into the 21 st Century, Madrid, Spain, 11/97.

                                                       - 29 -
Joe B. Putnam, Jr., M.D.                                                              Rev: May 2010

Presentations at National or International Conferences (cont.)

66.   3rd Annual Scientific Meeting Connective Tissue Oncology Society, Isolated Single Lung Perfusion with
      Adriamycin for Unresectable Sarcomatous Metastases, Milan, Italy, 11/97.
67.   Austin Surgical Society, Esophageal Cancer: What is the Right Operation? Austin, TX, 1/98.
68.   Pittsburgh Thoracic Surgical Society, Evolving Management of Pulmonary Metastases, Pittsburgh, PA, 3/98.
69.   Facing the Challenges of NSCLC: Innovations in Combined - Modality Treatment Strategies, Non - Small Cell
      Lung Cancer: Defining the Problem, Staging, and Surgical Management, San Diego, CA, 4/98.
70.   Facing the Challenges of NSCLC: Innovations in Combined - Modality Treatment Strategies, Non - Small Cell
      Lung Cancer: Defining the Problem, Staging, and Surgical Management, Los Angeles, CA, 4/98.
71.   Facing the Challenges of NSCLC: Innovations in Combined - Modality Treatment Strategies, Non - Small Cell
      Lung Cancer: Defining the Problem, Staging, and Surgical Management, Birmingham, AL, 4/98.
72.   Cancer Initiative 2000, Surgical Options in Non - Small Cell Lung Cancer, Dallas, TX, 4/98.
73.   American Radium Society Annual Meeting, New Approaches for a New Millennium, Non - Small Cell Lung
      Cancer Case Panel, Monte Carlo, Monaco, 5/98.
74.   Visiting Professor Lectureship Series, Allegheny General Hospital, Edward M. Kent, M.D., Pittsburgh, PA, 5/98.
75.   Institute for Continuing Healthcare Education: Facing the Challenges of NSCLC: Innovations in combined -
      Modality Treatment Strategies, Non - Small - Cell Lung Cancer: Defining the Problem, Staging, and Surgical
      Management, Washington DC, 6/98.
76.   Institute for Continuing Healthcare Education: Facing the Challenges of NSCLC: Innovations in combined -
      Modality Treatment Strategies, Non - Small - Cell Lung Cancer: Defining the Problem, Staging, and Surgical
      Management, Atlanta, GA, 6/98.
77.   Institute for Continuing Healthcare Education: Facing the Challenges of NSCLC, Non - Small - Cell Lung Cancer:
      Defining the Problem, Staging, and Surgical Management, Oklahoma City, OK, 6/98.
78.   Lorain County Physicians/Community College Continuing Medical Education Consortium, Annual
      Pulmonary/Critical Care Seminar: Multi - Modality Treatment of Lung Cancer, Cleveland, OH, 9/98.
79.   Institute for Continuing Healthcare Education: Facing the Challenges of NSCLC, Non - Small - Cell Lung Cancer:
      Defining the Problem, Staging, and Surgical Management Buffalo, New York, 9/98.
80.   Logical Communications, Inc.: Multimodality Approach to the Management of Malignancies of the Thorax, Non -
      Small - Cell Lung Cancer: Defining the Problem, Staging, and Surgical Management Role of Surgery in NSCLC
      and the Revised Staging System, San Antonio, TX, 10/98.
81.   5th National Thoracic and Cardiovascular Surgery Conference, Neoadjuvant Chemotherapy and Surgery in the
      Multimodality Treatment of Lung Cancer, Antalya, Turkey, 10/98.
82.   American College of Surgeons Annual Clinical Congress, Optimal Management of Malignant Effusions, Orlando,
      FL, 10/98.
83.   American College of Surgeons Annual Clinical Congress, Massive Mediastinal Tumors - A Surgical Dilemma,
      Orlando, FL. 10/98
84.   XXXI World Congress of the International College of Surgeons, Mediastinal Tumors, Buenos Aires, Argentina,
      11/98.
85.   XXXI World Congress of the International College of Surgeons, Treatment of Pulmonary Metastases, Buenos Aires,
      Argentina, 11/98.
86.   XXXI World Congress of the International College of Surgeons, Adjuvant Therapy in Advanced Pulmonary Cancer,
      Buenos Aires, Argentina, 11/98.
87.   XXXI World Congress of the International College of Surgeons, Pleural Mesothelioma, Buenos Aires, Argentina,
      11/98.
88.   XXXI World Congress of the International College of Surgeons, Indications in Thoracic Pathology, Buenos Aires,
      Argentina, 11/98.
89.   XXXI World Congress of the International College of Surgeons, Current State in the Surgical Treatment in
      Pulmonary Cancer, Buenos Aires, Argentina, 11/98.
90.   Southern Thoracic Surgical Association, Early Cost Comparison between Tube Thoracostomy vs. Chronic
      Indwelling Pleural Catheter (Pleurx) For Treatment of Malignant Pleural Effusion, Orlando, FL, 11/98.
91.   Emory University Conference, The Role of Surgery and Neoadjuvant Chemotherapy in the Management of
      Advanced Stage Lung Cancer, Atlanta, GA, 11/98.
92.   RSNA 1998 84th Scientific Assembly & Annual Meeting, Management Lung Cancer, Chicago, Ill, 12/98.
93.   The Society of Thoracic Surgeons 35th Annual Meeting, An Aggressive Multidisciplinary Surgical Approach to
      Superior Sulcus Tumors with Vertebral Invasion Can Lead to Long - Term Survival, San Antonio, TX, 1/99.
94.   11th Annual MASCC International Symposium Meeting, Chronic Indwelling Pleural Catheter (Pleurx®) for Cost
      Effective Management of Malignant Pleural Effusions, Nice, France, 2/99.

                                                       - 30 -
Joe B. Putnam, Jr., M.D.                                                                  Rev: May 2010

       Presentations at National or International Conferences (cont.)

95.    WellStar Promina Northwest Professional Cancer Education Program, Multimodality Approach in the Treatment of
       Lung Cancer, Marietta, GA, 3/99.
96.    Madigan Army Medical Center Grand Rounds and Chest Conference, The Multimodality Approach to Lung Cancer
       Tacoma, WA, 3/99.
97.    Visiting Professor, University of Toronto/Ontario Cancer Institute/Princess Margaret Hospital, Thoracic Oncology
       Tumour Conference, Evolving Management of Malignant Pleural Effusions Toronto, Ontario, Canada, 4/99.
98.    American Radium Society 81st Annual Meeting Esophagus Panel: Current Multidisciplinary Management for
       Cancer of the Esophagus, Role of Surgery for Esophageal Cancer, Big Island of Hawaii, 4/99.
99.    Japan/U.S. Cancer Therapy Symposium Post American Radium Society Meeting, Surgical Management for
       Carcinoma of the Esophagus: University of M.D. Anderson Cancer Experience, Hiroshima, Japan, 4/99.
100.   The Multidisciplinary Management of Thoracic Malignancies, Evolving Role of Surgery in the Management of
       Carcinoma of the Lung, Istanbul, Turkey, 6/99.
101.   The Multidisciplinary Management of Thoracic Malignancies, Management of Malignant Pleural Effusions,
       Istanbul, Turkey, 6/99.
102.   85th Annual Clinical Congress of the American College of Surgeons, Pulmonary Metastases San Francisco, CA
       10/99.
103.   1999 Annual Clinical Assembly of Osteopathic Specialists, Multimodality Treatment of Lung Cancer, Seattle, WA,
       10/99.American Society for Therapeutic Radiology and Oncology 41 st Annual Meeting, New Surgical Approaches
       in NSCLC, San Antonio, TX, 10/99.
104.   46th Annual Meeting Southern Thoracic Surgical Association, Thoracoscopy has a Limited role in Lung Surgery
       Especially in Malignant Disease, San Juan, Puerto Rico, 11/99.
105.   RSNA 85th Scientific Assembly and Annual Meeting, Diagnosis and Multidisciplinary Approach for Lung Cancer,
       Chicago, ILL, 12/99.
106.   Chest Disease Management Conference, Management of Malignant Pleural Effusion, Nashville, TN, 12/99.
107.   SPIE‟s BiOS 2000 The International Symposium on Biomedical Optics, Therapeutic Considerations of Heat -
       Induced Lung Injury, San Jose, CA 1/00.
108.   General Thoracic Surgical Club 13th Annual Meeting, Super Bowl of X - Rays, Tucson, AZ, 3/00.
109.   American Association of Thoracic Surgeons, Malignant Pleural Effusion, Toronto, Canada, 4/00.
110.   25th Year Lung Days, General Thoracic Surgery Course, Pulmonary Metastasectomy, Istanbul, Turkey, 5/00.
111.   25th Year Lung Days, General Thoracic Surgery Course, How To Do Research in Thoracic Surgery, Istanbul,
       Turkey, 5/00.
112.   25th Year Lung Days, General Thoracic Surgery Course, Management of Patients with Malignant Pleural Effusions
       Istanbul, Turkey, 5/00.
113.   25th Year Lung Days, General Thoracic Surgery Course, Pre - and Intra - operative Evaluation of Patients
       Undergoing Lung Resection Following Neo - adjuvant Chemotherapy for Lung Cancer, Istanbul, Turkey, 5/00.
114.   36th Annual ASCO Educational Symposia Meeting, Multidisciplinary Approach to the Management of Soft - Tissue
       Sarcomas, New Orleans, LA, 5/00.
115.   Scientific Advisory Board Meeting, Santa Fe, NM, 7/00
116.   2nd Annual Lung Outing, Neo Adjuvant Therapy NSCLC Multi - Modality Treatment of Lung Cancer, Oregon, OH,
       8/00.
117.   Illinois Thoracic Society Meeting, Induction Chemotherapy and Surgery for NSCLC, Chicago, IL, 9/00.
118.   MedSourceOne Continuing Education Program, Multimodality Treatment of Lung Cancer, Joplin, MO, 10/00.
119.   6th Turkish Thoracic and Cardiovascular Association Congress, The Clinical Basis for Surgery and Multidisciplinary
       Care in the Patient with Lung Cancer, Antalya, Turkey, 10/00.
120.   Southern Thoracic Surgical Association 47th Annual Meeting, Marco Island, FL, 11/00.
121.   Columbus Community Clinical Oncology Program, Neoadjuvant Chemotherapy and Surgery for Early Stage Lung
       Cancer, Dublin, OH, 11/00.
122.   Tumor Conference, Neoadjuvant Chemotherapy and Surgery for Early Stage Lung Cancer, Wheeling, WV, 12/00.
123.   Society of Thoracic Surgeons Meeting, National Database for Thoracic Surgeons, New Orleans, LA, 1/01.
124.   International Workshop for Lung Cancer Database Meeting, London, 2/01.
125.   General Thoracic Surgical Club, Clinical Trials Meeting, Captiva Island, FL, 3/01.
126.   The University of Texas M. D. Anderson Cancer Center, Conversations about Cancer Research, Naples, FL, 3/01.
127.   Japan/US Cancer Therapy Symposium, the Evolution of Neoadjuvant Therapy for Esophageal Carcinoma:
       University of Texas M. D. Anderson Cancer Center Experience, La Jolla, California, 4/01.
128.   American Radium Society Meeting, Moderate session on Chest, Coronado, CA, 4/01.
129.   The American Association for Thoracic Surgeons 81st Annual Meeting, Vertebrectomy and Reconstruction for
       Tumors Invading the Spine, San Diego, CA, 5/01.
                                                          - 31 -
Joe B. Putnam, Jr., M.D.                                                              Rev: May 2010

      Presentations at National or International Conferences (cont.)

130. STS Coding Workshop Meeting, Reimbursement for Thoracic surgeons: A “Political” Process, New Orleans, LA,
     5/01.
131. SCO Annual Meeting, PET Scanning in Resectable NSCLC, San Francisco, CA, 5/01.
132. Bristol - Myers Squibb International Oncology Visiting Faculty Program, A Role for Pre - and Post - Adjuvant
     Chemotherapy in early Stage NSCLC, Yokohama, Japan, 7/01.
133. Tenth G. Rainey Williams Surgical Symposium, Management of Non - Small Cell Lung Cancer: Neoadjuvant,
     Adjuvant or Neoadjuvant Support of Surgery, Oklahoma City, OK, 9/01.
134. Mayo Clinic Grand Rounds, The Evolution of Multidisciplinary Therapy for Lung Cancer: University of Texas M.
     D. Anderson Cancer Center Experience, Rochester, MN, 9/01.
135. 87th Annual Clinical Congress of the American College of Surgeons, Surgical Techniques and Results of
     Multimodality Therapy for Advanced Thymoma, New Orleans, LA, 10/01.
136. 6th Annual Perspectives in Thoracic Cancer, Management of Malignant Pleural Effusions, New York, NY, 10/01.
137. Thoracic Oncology Conference, Discussion of common and difficult lung cancer clinical scenarios, San Francisco,
     CA, 11/01.
138. Chest 2001 67th Annual International Scientific Assembly, Technical Challenges Pancoast, Carinal Resections and
     Patient Selection for and Techniques of Metastasectomy, Philadelphia, PA, 11/01.
139. STSA Annual Meeting, Coding and Reimbursement Workshop, San Antonio, TX, 11/01.
140. Riverside Methodist Hospital Grand Rounds, Lung Cancer Management, Columbus, OH, 11/01.
141. 1st SMCCC - MDACC International Joint Symposium, Advances in the Surgical Management of Lung Cancer,
     Seoul, Korea, 12/01.
142. 38th Annual STS Meeting, Thoracic Database, Fort Lauderdale, FL, 01/02.
143. Expanded Faculty Speaker Training Meeting, Inside Cancer: The Impact of EGFR - TK Inhibition on the Most
     Common Solid Tumors, Boca Raton, FL, 2/02.
144. IRESSA NSCL Advisory Board Meeting, Philadelphia, PA, 2/02.
145. General Thoracic Surgical Club 15th Annual Meeting, Lung Cancer with Satellite Nodules: Staging and
     Management, Tucson, AZ, 3/02.
146. XXXIII Peruvian International Congress of Surgery Meeting, Massive Mediastinal Tumors, Neoadjuvant Therapy
     in Cancer of the Lung, and Multimodality Treatment in Cancer of the Esophagus, Lima, Peru, 3/02.
147. Round Table Discussion/Tumor Board Meeting, S9900 Clinical Trial and Current Staging from the ATSERS
     Guidelines, Amarillo/Lubbock, TX, 4/02.
148. NATCH Study Meeting, Ongoing US and EU Trials in Neoadjuvant/Adjuvant Chemotherapy in NSCLC, Madrid,
     Spain, 4/02.
149. ERS Research Seminar Isolated Lung Perfusion, ILP for Sarcomatous Metastases, Edegem, Belgium, 4/02.
150. American Association for Thoracic Surgery, Managing Data: Thoracic Surgical Database Management, and
     Current Role of Induction Therapy, Washington, DC, 5/02.
151. ACOSOG Semi - Annual Meeting, Audit Committee, Toronto, Canada, 6/02.
152. IASLC Workshop Progress and Guidelines in the Management of Non Small Cell Lung Cancer, Induction
     Treatment before Surgery for Stage I and II, Bruges, Belgium, 9/02.
153. Duke UNC Lecture, Biology Basis for Multidisciplinary Management in Early and Locally Advanced Non Small
     Cell Lung Cancer, Chapel Hill, NC, 9/02.
154. 7th Annual Perspectives in Thoracic Cancer, The Management of Malignant Effusion, and Palliative Surgery for
     Specific Situations: Pancoast Tumors, Carinal Resections, Vertebral Invasion, New York, NY, 10/02.
155. 1st International Lung Cancer Conference, Surgical Advances for Locally Advanced Non - Small Cell Lung Cancer,
     Beijing, China, 11/02.
156. ACOSOG/DSMC Annual Meeting, Executive Committee, Chicago, IL, June 2004.
157. International Society of Gastrointestinal Oncology, Esophageal Cancer - Is Surgery Necessary for Cancer of the
     Esophagus? Arlington, VA, July 2004.
158. 17th Japan Chapter Congress of International Society of CT Surgery, The Surgical Management of Pulmonary
     Metastasis, Tokyo, Japan, July, 2004.
159. ACOSOG Mock Site Visit, Durham, NC, September 2004
160. NCI Lung Cancer Intergroup Meeting, Committee Updates, Bethesda, MD, September 2004.
161. Moderator, General Thoracic Track: Thoracic Surgery: 2010 & Beyond, STS/AATS Tech - Con Annual Meeting,
     San Diego, CA, January 2007.
162. American Board of Thoracic Surgery, Consultants Committee, Washington, DC, September 2004
163. ACOSOG Site Visit, Durham, NC, October 2004.
164. American College of Surgeons, Workforce meetings; Moderator - Postgraduate Course: Emerging Procedures in
     General Thoracic Surgery; Presenter - Radiofrequency ablation of lung tumors, New Orleans, LA, October 2004.
                                                        - 32 -
Joe B. Putnam, Jr., M.D.                                                                 Rev: May 2010

      Presentations at National or International Conferences (cont.)

165. Society of Thoracic Surgeons National Database Event, The Past, Present and the Future of the General Thoracic
     Surgery Database, Chicago, IL, October 2004.
166. 45th Annual Meeting of Japan Lung Cancer Society, IASLC Workshop, Surgical Problems after induction
     chemotherapy or chemoradiotherapy; Overview of resectable NSCLC - Evolving role of induction therapy;
     Perioperative evaluation of early stage NSCLC, Tokyo, Japan, October 2004.
167. 51st Annual Meeting Southern Thoracic Surgical Association, Surgical Approaches to Esophageal Carcinoma;
     Update on Coding, Cancun, Mexico, November 2004.
168. ACOSOG Executive Steering Committee, Chicago, IL, November 2004. 41st Annual Meeting of the Society of
     Thoracic Surgeons, Morbidity and Mortality of Major Pulmonary Resections in Patients with Early - Stage Lung
     Cancer: Initial Results of the Randomized, Prospective ACOSOG Z0030 Trial, Tampa, FL, January 2005.
169. ACOSOG Semiannual Meeting, Executive Committee; Thoracic Organ Site Committee, San Antonio, TX, January
     2005.
170. Harvard School of Public Health Center for Continuing Professional Education, Programs for Chiefs of Clinical
     Services, Group Discussion Leader, Boston, MA, January 2005.
171. American Society of Clinical Oncology, Innovations in Mediastinal Staging & Response in Lung Cancer , Orlando,
     FL, May 13 and 15, 2005.
172. American Society of Clinical Oncology, Operable Esophageal Cancer: Therapeutic Strategies, Orlando, FL. May
     16, 2005.
173. IASLC 11th World Conference on Lung Cancer, Discussant in Oral Sessions of Surgery Papers, Barcelona, Spain,
     July 2005.
174. IASLC 11th World Conference on Lung Cancer, Plenary Session - The Robert Ginsberg Lecture: Surgical
     Approaches to Lung Cancer, Barcelona, Spain, July 2005.
175. 4th Annual Symposium on Gastrointestinal Cancers: An update on advances in diagnosis and management.
176. “Chemoradiation in esophageal cancer: Before/after/instead of surgery” St. Louis University, St. Louis, MO,
     October 1, 2005.
177. Society of Thoracic Surgery 42nd Annual Meeting: Panel Moderator, “Frontiers in Diagnosis and Management”;
     Presenter: “Endobronchial Ultrasound in Stating of Thoracic Malignancy”; Panel Moderator: “Advances in
     Management of Barrett‟s Epithelium and Esophageal Cancer”, Chicago, IL, January, 2006.
178. Identification and Prevention of Surgical Site Infections (SSI) Roundtable, Medi - Flex, Inc., Dallas, TX, January,
     2006.
179. General Thoracic Surgery Club, “Management of Malignant Pleural Effusions” Tucson, AZ, March 11, 2006
180. Society of Thoracic Surgeons General Thoracic Surgery Symposium. “Resection for Lung Cancer” San Diego, CA,
     January 28, 2007
181. American Association for Thoracic Surgery General Thoracic Surgery Symposium, "Indwelling Pleural Catheters."
     Philadelphia, PA, April 30, 2006.
182. West Japan Thoracic Oncology Group (WJTOG) 2nd International Symposium on Lung Cancer Clinical Trial”, Nara
     - Ken, Japan, July 7, 2006.
183. Kent Trinkle Lecture, Southern Thoracic Surgical Association, “History of Residency Education At Vanderbilt
     University”, Tucson, AZ, November 2006.
184. American Association of Thoracic Surgeons Annual Meeting. “Controversies in Cardiothoracic Surgery”,
     Washington, DC, May, 2007.
185. IASLC World Congress on Lung Cancer, “M19 - 01 Treatment of IIIA Overview”, Seoul, Korea, September, 2007.
186. Society of Thoracic Surgeons Annual Meeting, General Thoracic Surgery Symposium: “Revising the Staging System”;
     Ft. Lauderdale, FL, January, 2008.
187. Japanese Association for Chest Surgery, “Beyond Mechanical Therapy: The Role of Adjuvant Chemotherapy for
     Non - Small Cell Lung Carcinoma”; Utsunomiya, Japan, May, 2008.
188. 2008 Evidence to Outcomes Conference, What‟s Right in Healthcare; “Teaching Physician - Patient Communication
     (AIDETSM) for Results in All Pillars”; The Studer Group, Atlanta, GA; June, 2008.
189. 79th Argentine Congress on Surgery; Buenos Aires, Argentina; “Thymoma”, “Esophageal Cancer Treatment”,
     “Open Thoracotomy v. VATS Resection for Lung Cancer. Are they the same from an oncological point of view?”,
     “Stage III Lung Cancer”, November 11 - 13, 2008.
190. Society of Thoracic Surgeons Annual Meeting, “Lung Cancer Staging: What‟s Up?”, San Francisco, CA, January
     23-28, 2009.
191. Sixth Annual Winter Lung Cancer Conference, “New Tools in Surgical Management of Lung Cancer”; Sunny Isles
     Beach, FL, March, 2009.
192. American Association for Thoracic Surgery Annual Meeting, “Non-small Cell Lung Cancer”, Boston, MA, May 9-
     11, 2009.
                                                         - 33 -
Joe B. Putnam, Jr., M.D.                                                                    Rev: May 2010

         Presentations at National or International Conferences (cont.)

193. International Association of Lung Cancer Annual Meeting, “Adjuvant Chemotherapy: Stage Specific Discussion”,
     “Indications for and Outcomes of Surgery for Metastatic Disease, Primary Lung Cancer, and Mediastinal Nodal
     Involvement”, “Surgery for NSCLC: Node Dissections, outcome Analysis and VATS Surgery”, San Francisco,
     CA, July 31 – Aug 4, 2009.
194. International Lung Cancer Symposium, “Surgery in Locally-Advanced Disease”, “From Theory to Practice:
     Premature Disease”, “Surgical Controversies”, “State of the Art: Mesothelioma”, Sirio Libanes Hospital, Sao Paulo,
     Brazil, Sept 9-13, 2009.
195. ESTS School of Thoracic Surgery, Covidien European Training Center, “Minimally Invasive Lung Surgery and
     Associated Treatments Session: “Neoadjuvant and adjuvant treatments for resected NSCLC: Complications and
     Results, Elancourt, France; October 2009.
196. ESTS School of Thoracic Surgery, Covidien European Training Center, “Radiofrequency Ablation (RFA) and
     Cryotherapy (CR) for Pulmonary Session: Radiofrequency ablation (RFA) and Cryotherapy (CR) for pulmonary
     lesions: Indications of RFA”, “Techniques, complications and results of RFA”, Elancourt, France; October 2009.
197. American College of Surgeons Annual Meeting: “Current Therapeutics for High-Risk Patients; Non-Small Cell
     Lung Cancer: “Standard of Care is Lobectomy: Why not Wedge Resection?”, Chicago, IL; October 2009.
198. Society of Thoracic Surgeons Annual Meeting, Discussant, “J. Maxwell Chamberlain Memorial Paper for General
     Thoracic Surgery: Predictors of Mortality and Major Morbidity After Resection for Lung Cancer – A Society of
     Thoracic Surgeons General Thoracic Surgery Database Risk Model.; Ft. Lauderdale, FL; January 26, 2010.
199. Society of Thoracic Surgeons Annual Meeting, “Separating the wheat from the chaff: Is it time for a model that
     predicts benign disease in patients with pulmonary nodules?”; Ft. Lauderdale, FL; January 26, 2010.
200. European Lung Cancer Conference: “Controversy Session: Stage IIIA N2 NSCLC: Surgery has no role to play in
     Stage III NSCLC”, Geneva, Switzerland, April 28, 2010.

Seminar Invitations from Other Institutions

     Lectureships and Visiting Professorships

    1.     Visiting Professor, University of Tennessee Medical School, Memphis, TN , 1995
    2.     Visiting Professor, University of Toronto, Mount Sinai Hospital, 1995
    3.     Visiting Professor Lectureship Series, Allegheny General Hospital, Edward M. Kent, M.D., Pittsburgh, PA, 1998.
    4.     Visiting Professor, University of Toronto/Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario,
           Canada, 4/99.
    5.     Visiting Professor, The Mayo Clinic, Rochester, MN, 2001
    6.     Visiting Professor, The Carolinas Heart Institute, Carolinas Medical Center, Charlotte, NC, 2002
    7.     General Thoracic Surgery Visiting Professor, Rush Medical Center Grand Rounds, Chicago, IL, December, 2004
    8.     Visiting Professor, Scott & White Hospital, Temple, TX, April, 2005.
    9.     The 2nd Annual Evelyn Grollman Glick Lectureship in Thoracic Surgery, Johns Hopkins Hospital, Baltimore,
           MD, May 5, 2005
    10.    Craighead Visiting Professor, Louisiana State University, New Orleans, LA, May 10, 2005
    11.    Grand Rounds Presentation, Aultman Cancer Center, Dayton, OH, April 2006.
    12.    Sommer Memorial Lectureship, Oregon Health Science University, Portland, OR, May 11 - 12th, 2006
    13.    Visiting Professor, Emory University, Atlanta, GA, Oct 2 – 3, 2008
    14.    Medical Center of Bowling Green (KY) CME Program, “American Joint Committee on Cancer (AJCC) Staging
           of Lung Cancer”, August, 2009.
    15.    Memorial Medical Center Grand Rounds, “Advancing Surgery: The Role of Quality Improvement and Clinical
           Trials”; Savannah, GA; October, 2009.
    16.    CME Symposium, St. Mary‟s Hospital, Knoxville, TN: “American Joint Committee on Cancer (AJCC) Staging
           of Lung Cancer”; November, 2009.

    Other Presentations (state, local) Conferences

    1.     University of Texas Health Science Center, Limits of Surgical Resectability of Carcinoma of the Lung, Houston,
           TX, 10/89.
    2.     Critical Care Conference, Surgical Resection for Primary Carcinoma of the Lung, University of Texas MD
           Anderson Cancer Center, Houston, TX, 4/90.
    3.     General Surgery Grand Rounds, University of Texas Medical School at Houston and Hermann Hospital -
           Diagnostic and Management of Gastroesophageal Reflux, 6/91.
                                                            - 34 -
Joe B. Putnam, Jr., M.D.                                                                 Rev: May 2010


          Other Presentations (state, local) Conferences (cont.)

    4.    Surgical Grand Rounds, University of Texas Health Science Center at Houston - Management of Pulmonary
          Metastases, 9/91
    5.    Pathophysiology Conference, The University of Texas Health Science Center at Houston, Lung Carcinoma, 5/92
    6.    ATLS Provider Course, The University of Texas Medical School, Airway Management, 6/92
    7.    University of Texas M.D. Anderson Cancer Center, Surgery Symposium, Minimally Invasive Surgery in
          Oncology, Thoracoscopic Resection of Mediastinal Tumors, Houston, TX, 12/92.
    8.    Supportive Care Forum, University of Texas M.D. Anderson Cancer Center, Management of Pleural Effusion and
          Ascites in Cancer Patients, 12/92
    9.    Minimal Access Surgery in Cancer Management Symposium, University of Texas M.D. Anderson Cancer Center,
          Video Assisted Thoracoscopy, 12/92.
    10.   Freshmen Medical Student Conference, University of Texas M.D. Anderson Cancer Center, Thoracic Surgical
          Oncology, 7/93.
    11.   Houston Cancer Institute 9th Annual Cancer Conference, Role of Surgery and its Operative Stages in the
          Treatment of Non - Oat Cell Lung Cancer, Spring Branch Memorial Hospital, Houston, TX, 10/93.
    12.   American Society of Abdominal Surgeons, 35th Clinical Congress of Abdominal Surgeons, Barrett‟s Esophagus,
          Houston, TX, 4/94.
    13.   American Society of Abdominal Surgeons, 35th Clinical Congress of Abdominal Surgeons, Surgical Management
          of Esophageal Carcinoma, Houston, TX, 4/94.
    14.   Thoracic Surgery Journal Club Meeting, Veterans Hospital, Houston, TX, Esophageal Carcinoma, 5/94.
    15.   ATLS Provider Course, Southeast Trauma Educational Foundation, Houston, TX, June 14 - 25, 1994.
    16.   Advanced Cardiac Life Support (ACLS) Provider Course, Acid - Base Balance. University of Texas M.D.
          Anderson Cancer Center, Houston, Texas, 7/94.
    17.   Advanced Cardiac Life Support (ACLS) Provider Course, Airway Adjuncts and Intubation, University of Texas
          M.D. Anderson Cancer Center, Houston, TX, 7/94.
    18.   Houston Northwest Medical Center, Neo - adjuvant Chemotherapy plus Surgery in the Treatment of Potentially
          Resectable Non - small Cell Lung Cancer, Houston, TX, 9/94.
    19.   Texas Thoracic Society, Texas Pulmonary Medicine: A Comprehensive Review and Update, South Shore Harbor
          Resort and Conference Center, League City, TX, 3/95.
    20.   Thoracic Basis Science Lecture Series, Lung Cancer III, Baylor College of Medicine, Houston, TX, 7/95.
    21.   Thoracic Basis Science Lecture Series,” Esophageal Cancer II, Baylor College of Medicine, Houston, TX, 9/95.
    22.   Surgery Grand Rounds, Current Management of Esophageal Cancer, University of Texas Medical School and
          Hermann Hospital, Houston, TX, 11/95.
    23.   Surgery Grand Rounds, Evolving Surgical Management of Pulmonary Metastases, University of Texas Medical
          School and Hermann Hospital, Houston, TX, 11/96.
    24.   Thoracic Basic Science Lecture Series, Pulmonary Metastases, Baylor College of Medicine, Houston, TX, 2/97.
    25.   Thoracic Basic Science Lecture Series, Malignant Pleural Effusions, Baylor College of Medicine, Houston, TX,
          3/97.
    26.   3rd Advanced Closed Circuit Endoscopy, Approach to Gastroesophageal Tumors, Houston, TX, 11/97.
    27.   3rd Advanced Closed Circuit Endoscopy (ACE), Surgeon‟s Point of View, University of Texas M.D. Anderson
          Cancer Center, Houston, TX, 11/97.
    28.   Journal Club Conference, The Use of the Denver Catheter to Manage Pleural Effusion, The Department of
          Thoracic/Head and Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX,
          1/98.
    29.   Lung Cancer Therapy Retreat, Pulmonary Perfusion, University of Texas M.D. Anderson Cancer Center,
          Houston, TX, 2/98.
    30.   41st Annual Clinical Conference, New Frontiers in Research and Treatment of Aerodigestive Tract Cancers, What
          is the Right Operation for Cancer of the Esophagus?, University of Texas M.D. Anderson Cancer Center,
          Houston, TX, 4/98.
    31.   Grand Rounds, UT Medical Health Science Center, Indications and Results of Lung Resection for Metastases,
          Houston, TX, 9/98.
    32.   The Third Houston Pulmonary and Critical Care Update, Multimodality Modality Treatment of Advanced Stage
          Carcinoma of the Lung, Houston, TX, 9/98.
    33.   Thoracic Basic Science Lecture Series, Malignant Pleural Effusions, Baylor College of Medicine, Houston, TX,
          9/98.
    34.   Grand Rounds, Evolving Role of the Surgeon in the Management of Advanced Stage Lung Cancer, Baylor
          College of Medicine, Houston, TX, 9/99.
                                                          - 35 -
Joe B. Putnam, Jr., M.D.                                                             Rev: May 2010

        Other Presentations (state, local) Conferences (cont.)

    35. Cancer Care, University of Texas M.D. Anderson Approach, Surgical Approach to Lung Cancer, University of Texas
        M.D. Anderson Cancer Center, Houston, TX, 10/99
    36. Houston Surgical Society Lecture, Carcinoma of the Esophagus, Houston, TX, 10/00.
    37. Cancer Advisory Committee, Tumor Board: Emphasis on Thoracic Tumors, Houston, TX, 4/01.
    38. Grand Rounds Session Pearls - The Art and Science of Medicine, “Outpatient Management of Malignant Pleural
        Effusions”, University of Texas M. D. Anderson Cancer Center, 6/01.
    39. AstraZeneca Preceptorship Program, Surgical Approaches to NSCLC, M. D. Anderson Cancer Center, Houston, TX,
        2/02
    40. Spring Branch Medical Center 19th Annual Cancer Conference, Update on the Management of Lung Cancer, Houston,
        TX, 10/02.
    41. University of Texas Health Science Center at Houston, Student Surgical Association Lecture Series, Houston, TX,
        11/02.
    42. Nashville Surgical Society, Clinical Data Collection at the Point of Decision: A Model for Quality Improvement,
        Nashville, TN, 09/04.
    43. Vanderbilt - Ingram Cancer Center, 2006 Spring Scientific Conference, Resection of Thoracic Neoplasms:
        Implications for Multimodality Therapy, 04/06.
    44. 2nd Annual Advanced Lung Disease and Critical Care Conference, “New Treatment for Lung Cancer – the Cutting
        Edge”, Vanderbilt University Medical Center, Nashville, TN, December, 2006.
    45. Vanderbilt Ingram Cancer Center Fall Oncology Conference, “The Role of Adjuvant Therapy Following
        Resection of Non - Small Cell Lung Cancer: A Surgeon‟s Perspective.” Braselton, GA, October, 2006.
    46. Riverside Hospital Grand Rounds, “Lung Cancer: Proposed Revisions in Lung Cancer Staging and Implications for
        Multi - Modality Therapy”; Columbus, OH, November 2007.
    47. 32nd Matthew Walker Surgical Symposium, “Multidisciplinary Management Strategies for Esophageal
        Carcinoma”; Meharry Medical College, Nashville, TN, May, 2008.
    48. Vanderbilt University Medical Center Department of Thoracic Surgery: Advances in the Treatment of Thoracic
        Diseases: Lung Cancer Management Strategies and Practice. Speaker, “Update on Staging for Lung Cancer” ,
        Moderator, Panel Discussion and Case Presentation, Nashville, TN, May 16, 2009.
    49. Southern Thoracic Surgical Association Annual Meeting, “Accuracy of Surgeon and Trainee Estimates of Lung
        Resection Risk”, “Role of a Serum Proteomic Signature in the Management of Pulmonary Nodules” Marco
        Island, FL; November, 2009.
    50. Vanderbilt University Medical Center Department of Thoracic Surgery: Advances in the Management of
        Thoracic Diseases 2010: Multidisciplinary Evaluation and Therapy. “Consequences of the New Lung Cancer
        Staging system (AJCC 7th Edition)”, and “Modern Management of Pleural Space Problems”; Panel Moderator:
        “Solitary Pulmonary Nodule”, “Staging of Lung Cancer with Radiology and EBUS”, “Evaluation of End-Stage
        Lung Disease”, “Barrett‟s Esophagus with High-Grade Dysplasia”, “Paraesophageal Hernia in the Elderly”,
        “Dysphagia (Esophageal Carcinoma)” Nashville, TN, April 24, 2010.




                                                        - 36 -

								
To top